00000000|MMI|3.65|Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2598112|[clna]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|91/14|
00000000|MMI|3.65|Date of admission|C1302393|[tmco]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|91/14|
00000000|MMI|3.65|Report status|C0586177|[fndg]|["Report status"-tx-1-"Report Status"-noun-0]|TX|117/13|
00000000|MMI|3.59|Pyrexia of unknown origin (excl puerperal)|C0856281|[sosy]|["puo"-tx-1-"PUO"-noun-0]|TX|12/3|
00000000|MMI|3.46|Congestive heart failure|C0018802|[dsyn]|["CHF"-tx-1-"CHF"-noun-0]|TX|64/3|
00000000|MMI|3.46|Diagnostic interview schedule|C0451119|[inpr]|["DIS"-tx-1-"DIS"-noun-0]|TX|85/3|
00000000|MMI|3.46|Discontinued|C1444662|[fndg]|["DIS"-tx-1-"DIS"-noun-0]|TX|85/3|
00000000|MMI|204.62|Portugal|C0032729|[geoa]|["PO"-tx-10-"PO"-noun-0,"PO"-tx-9-"PO"-noun-0,"PO"-tx-5-"PO"-noun-0,"PO"-tx-4-"PO"-noun-0,"PO"-tx-3-"PO"-noun-0,"PO"-tx-2-"PO"-noun-0]|TX|[1794/2],[2022/2],[2102/2],[2143/2],[2279/2];1644/2;1358/2;1222/2;[963/2],[1061/2],[1120/2];[378/2],[418/2],[771/2]|Z01.542.727
00000000|MMI|116.52|Daily|C0332173|[tmco]|["Daily"-tx-46-"daily"-adv-0,"/day"-tx-44-"day"-noun-0,"QD"-tx-44-"qd"-noun-0,"QD"-tx-28-"qd"-noun-0,"QD"-tx-10-"QD"-noun-0,"QD"-tx-9-"QD"-noun-0,"QD"-tx-3-"QD"-noun-0,"/day"-tx-2-"DAY"-noun-0,"QD"-tx-2-"QD"-noun-0]|TX|6469/5;6342/3;[6154/2],[6177/2],[6205/2];4859/2;[1797/2],[2105/2],[2190/2],[2282/2];1647/2;[966/2],[1123/2];488/3;381/2|
00000000|MMI|106.45|Patient Discharge|C0030685|[hlca]|["Discharge"-tx-51-"DISCHARGE"-noun-0,"Discharge"-tx-48-"DISCHARGE"-noun-0,"Discharge"-tx-13-"DISCHARGE"-noun-0,"Discharge"-tx-2-"DISCHARGE"-verb-0,"Discharge"-tx-1-"DISCHARGE"-noun-0,"Patient Discharge"-tx-1-"DISCHARGE PATIENT"-noun-0]|TX|6791/9;6550/9;2667/9;327/9;33/9;108/17|E02.204.125;E02.760.400.610;N02.421.192.125;N02.421.585.400.610;N04.590.233.727.210.125
00000000|MMI|79.95|Togo|C0040363|[geoa]|["TO"-tx-44-"to"-adv-0,"TO"-tx-41-"to"-adv-0,"TO"-tx-28-"to"-adv-0,"TO"-tx-21-"to"-adv-0,"TO"-tx-3-"to"-adv-0]|TX|6326/2;5843/2;4876/2;4413/2;1034/2|Z01.058.290.190.800
00000000|MMI|79.95|Tryptophanase|C0041260|[aapp,enzy]|["TO"-tx-44-"to"-adv-0,"TO"-tx-41-"to"-adv-0,"TO"-tx-28-"to"-adv-0,"TO"-tx-21-"to"-adv-0,"TO"-tx-3-"to"-adv-0]|TX|6326/2;5843/2;4876/2;4413/2;1034/2|D08.811.520.224.800
00000000|MMI|79.83|Coding|C0009219|[ocac]|["code"-tx-44-"CODE"-verb-0,"code"-tx-44-"Code"-noun-0,"code"-tx-2-"CODE"-noun-0,"code"-tx-2-"code"-noun-0]|TX|6027/4;6022/4;274/4;292/4|N04.452.758.708.200.400.500;N04.452.859.564.274;N05.715.360.300.715.500.249;N06.850.520.308.940.968.249
00000000|MMI|73.21|Lesotho|C0023376|[geoa]|["LT"-tx-10-"lt"-noun-0,"LT"-tx-9-"lt"-noun-0,"LT"-tx-3-"lt"-noun-0,"LT"-tx-2-"lt"-noun-0]|TX|1836/2;1663/2;982/2;[844/2],[856/2]|Z01.058.290.175.400
00000000|MMI|72.33|Oral|C0442027|[spco]|["PO"-tx-10-"PO"-noun-0,"PO"-tx-9-"PO"-noun-0,"PO"-tx-5-"PO"-noun-0,"PO"-tx-4-"PO"-noun-0,"PO"-tx-3-"PO"-noun-0,"PO"-tx-2-"PO"-noun-0]|TX|[1794/2],[2022/2],[2102/2],[2143/2],[2279/2];1644/2;1358/2;1222/2;[963/2],[1061/2],[1120/2];[378/2],[418/2],[771/2]|
00000000|MMI|71.20|Panama|C0030266|[geoa]|["PM"-tx-51-"PM"-noun-0,"PM"-tx-49-"pm"-adj-0,"PM"-tx-13-"pm"-adj-0,"PM"-tx-12-"pm"-adj-0,"PM"-tx-11-"pm"-adj-0,"PM"-tx-1-"PM"-adj-0]|TX|6774/2;6681/2;2586/2;2537/2;2490/2;147/2|Z01.107.169.772
00000000|MMI|70.87|Mongolia|C0026410|[geoa]|["MG"-tx-10-"MG"-noun-0,"MG"-tx-9-"MG"-noun-0,"MG"-tx-3-"MG"-noun-0]|TX|[1791/2],[2019/2],[2099/2],[2140/2];1641/2;1058/2|Z01.252.474.651
00000000|MMI|67.73|Procrit|C0733467|[aapp,phsu]|["Procrit"-tx-44-"procrit"-noun-0,"Procrit"-tx-42-"Procrit"-noun-0,"Procrit"-tx-2-"PROCRIT"-noun-0]|TX|6260/7;5887/7;501/7|D12.644.276.374.410.240.150.500;D12.776.395.240.150.750;D12.776.467.374.410.240.150.500;D23.529.374.410.240.150.750
00000000|MMI|67.11|Simvastatin|C0074554|[orch,phsu]|["SIMVASTATIN"-tx-9-"SIMVASTATIN"-noun-0,"SIMVASTATIN"-tx-5-"SIMVASTATIN"-noun-0,"SIMVASTATIN"-tx-4-"SIMVASTATIN"-noun-0]|TX|1576/11;1301/11;1210/11|D02.455.426.559.847.638.400.900;D04.615.638.400.900
00000000|MMI|63.39|diagnosis aspect|C1704338|[qlco]|["diagnosis"-tx-13-"DIAGNOSIS"-noun-0,"diagnosis"-tx-2-"Diagnosis"-noun-0]|TX|[2621/9],[2759/9];678/9|x.x.x.x.x.x.x
00000000|MMI|60.92|Pharmacogenomics Trial Characteristics Domain|C3714755|[inpr]|["PT"-tx-43-"Pt"-noun-0,"PT"-tx-41-"pt"-noun-0,"PT"-tx-38-"Pt"-noun-0,"PT"-tx-36-"Pt"-noun-0,"PT"-tx-36-"pt"-noun-0,"PT"-tx-35-"Pt's"-noun-0,"PT"-tx-31-"PT"-noun-0,"PT"-tx-28-"Pt"-noun-0,"PT"-tx-26-"Pt"-noun-0,"PT"-tx-24-"Pt"-noun-0,"PT"-tx-22-"pt"-noun-0,"PT"-tx-21-"pt"-noun-0,"PT"-tx-15-"Pt"-noun-0]|TX|5943/2;5806/2;5498/2;5363/2;5392/2;5305/4;5141/2;4839/2;4754/2;4548/2;4465/2;4369/2;3663/2|
00000000|MMI|60.92|Physical therapy (field)|C0699718|[bmod]|["PT"-tx-43-"Pt"-noun-0,"PT"-tx-41-"pt"-noun-0,"PT"-tx-38-"Pt"-noun-0,"PT"-tx-36-"Pt"-noun-0,"PT"-tx-36-"pt"-noun-0,"PT"-tx-35-"Pt's"-noun-0,"PT"-tx-31-"PT"-noun-0,"PT"-tx-28-"Pt"-noun-0,"PT"-tx-26-"Pt"-noun-0,"PT"-tx-24-"Pt"-noun-0,"PT"-tx-22-"pt"-noun-0,"PT"-tx-21-"pt"-noun-0,"PT"-tx-15-"Pt"-noun-0]|TX|5943/2;5806/2;5498/2;5363/2;5392/2;5305/4;5141/2;4839/2;4754/2;4548/2;4465/2;4369/2;3663/2|
00000000|MMI|59.17|Physicians|C0031831|[prog]|["DR"-tx-44-"Dr"-noun-0,"PHYSICIAN"-tx-38-"physician"-noun-0,"DR"-tx-12-"Dr"-noun-0,"DR"-tx-11-"Dr"-noun-0,"DR"-tx-10-"Dr"-noun-0]|TX|6294/2;5566/9;2552/2;2505/2;2457/2|M01.526.485.810;N02.360.810
00000000|MMI|57.93|Kidney Failure|C0035078|[dsyn]|["Failure, Renal"-tx-32-"renal failure"-noun-0,"Failure, Renal"-tx-24-"renal failure"-noun-0,"Renal Insufficiency"-tx-13-"renal insufficiency"-noun-0]|TX|5211/13;4643/13;[2941/19],[2963/19]|C12.777.419.780;C13.351.968.419.780
00000000|MMI|57.68|Dominican Republic|C0013014|[geoa]|["DR"-tx-44-"Dr"-noun-0,"DR"-tx-12-"Dr"-noun-0,"DR"-tx-11-"Dr"-noun-0,"DR"-tx-10-"Dr"-noun-0]|TX|6294/2;2552/2;2505/2;2457/2|Z01.107.084.900.300;Z01.639.880.300
00000000|MMI|57.13|Food-Drug Interactions|C0242785|[dsyn]|["Interaction, Food-Drug"-tx-10-"Food/Drug Interaction"-noun-0,"Interaction, Food-Drug"-tx-9-"Food/Drug Interaction"-noun-0,"Interaction, Food-Drug"-tx-5-"Food/Drug Interaction"-noun-0,"Interaction, Food-Drug"-tx-2-"Food/Drug Interaction"-noun-0]|TX|1842/21;1669/21;1365/21;862/21|G07.690.773.968.511
00000000|MMI|55.10|Nephrotic Syndrome|C0027726|[dsyn]|["-- Nephrotic Syndrome"-tx-13-"nephrotic syndrome"-noun-0]|TX|[3118/18],[3139/18],[3339/18]|C12.777.419.630.643;C13.351.968.419.630.643
00000000|MMI|52.93|Citrus paradisi|C0947567|[plnt]|["grapefruit"-tx-9-"grapefruit"-noun-0,"grapefruit"-tx-5-"grapefruit"-noun-0]|TX|1709/10;1405/10|B01.650.940.800.575.100.875.177.538
00000000|MMI|50.85|Lasix|C0699992|[orch,phsu]|["Lasix"-tx-47-"lasix"-noun-0,"Lasix"-tx-25-"lasix"-noun-0,"Lasix"-tx-2-"LASIX"-noun-0]|TX|6543/5;4705/5;743/5|D02.065.884.725.300;D02.092.146.807.300;D02.886.590.700.725.300
00000000|MMI|46.54|Dyspnea|C0013404|[sosy]|["SHORTNESS OF BREATH"-tx-45-"shortness of breath"-noun-0,"SOB"-tx-13-"SOB"-noun-0,"SHORTNESS OF BREATH"-tx-10-"Shortness of Breath"-noun-0,"SOB"-tx-2-"SOB"-noun-0]|TX|6422/19;3455/3;2322/19;672/3|C08.618.326;C23.888.852.371
00000000|MMI|44.54|Rocaltrol|C0592076|[horm,orch,phsu]|["Rocaltrol"-tx-44-"Rocaltrol"-noun-0,"Rocaltrol"-tx-2-"ROCALTROL"-noun-0]|TX|6230/9;384/9|D04.808.247.222.159.478.387.300;D04.808.247.808.146.478.387.300;D04.808.812.768.196.478.387.300;D10.570.938.146.478.387.300
00000000|MMI|39.16|Lantus|C0876064|[aapp,phsu]|["Lantus"-tx-40-"lantus"-noun-0,"Lantus"-tx-10-"LANTUS"-noun-0]|TX|5679/6;2150/6|D06.472.699.587.200.300.100;D12.644.548.586.200.300.100
00000000|MMI|38.96|therapeutic aspects|C0039798|[ftcn]|["treatment"-tx-13-"Treatment"-noun-0,"treatment"-tx-2-"Treatment"-noun-0]|TX|2821/9;715/9|x.x.x.x.x.x.x
00000000|MMI|37.31|Congestive heart failure|C0018802|[dsyn]|["CHF"-tx-49-"CHF"-noun-0,"CHF"-tx-32-"CHF"-noun-0,"CHF"-tx-23-"CHF"-noun-0,"CHF"-tx-14-"CHF"-noun-0,"CHF"-tx-13-"CHF"-noun-0,"CONGESTIVE HEART FAILURE"-tx-13-"congestive heart failure"-noun-0]|TX|6649/3;5240/3;4529/3;3562/3;[2565/3],[2736/3],[3321/3];[2632/24],[2985/24],[3012/24]|
00000000|MMI|34.73|Chronic Obstructive Airway Disease|C0024117|[dsyn]|["-- COPD"-tx-13-"COPD"-noun-0,"-- COPD"-tx-13-"copd"-noun-0,"CHRONIC OBSTRUCTIVE PULMONARY DISEASE"-tx-13-"chronic obstructive pulmonary disease"-noun-0]|TX|3360/4;3039/4;3046/37|C08.381.495.389
00000000|MMI|34.49|Physical Dialysis|C0011945|[npop]|["Dialysis"-tx-36-"dialysis"-noun-0,"Dialysis"-tx-35-"dialysis"-noun-0,"Dialysis"-tx-30-"dialysis"-noun-0]|TX|5432/8;5330/8;5040/8|E05.196.353;G02.149.767.540;G02.842.750.540
00000000|MMI|33.68|Angina Pectoris|C0002962|[fndg]|["ANGINA"-tx-23-"angina"-noun-0,"ANGINA"-tx-21-"angina"-noun-0]|TX|4510/6;4402/6|C10.597.617.192.500;C14.280.647.187;C14.907.585.187;C23.888.592.612.233.500
00000000|MMI|30.97|Niacin|C0027996|[phsu,vita]|["NIACIN"-tx-8-"NIACIN"-noun-0,"NIACIN"-tx-4-"NIACIN"-noun-0]|TX|1552/6;1277/6|D03.066.515.475;D03.383.725.547.475
00000000|MMI|30.97|Renal Insufficiency|C1565489|[dsyn]|["RENAL INSUFFICIENCY"-tx-13-"renal insufficiency"-noun-0]|TX|[2941/19],[2963/19]|C12.777.419.780;C13.351.968.419.780
00000000|MMI|30.21|Kidney|C0022646|[bpoc]|["Renal"-tx-42-"renal"-adj-0,"Renal"-tx-31-"RENAL"-adj-0,"KIDNEY"-tx-12-"Kidney"-noun-0]|TX|5899/5;5134/5;2517/6|A05.810.453
00000000|MMI|28.28|Iodides|C0021966|[inch]|["I-"-tx-29-"I"-noun-0,"I-"-tx-25-"I"-noun-0]|TX|4897/1;4730/1|D01.248.497.158.490;D01.475.410
00000000|MMI|28.25|Mupirocin|C0085259|[antb,orch]|["MUPIROCIN"-tx-44-"Mupirocin"-noun-0,"MUPIROCIN"-tx-3-"MUPIROCIN"-noun-0]|TX|6308/9;989/9|D02.355.291.411.658;D03.383.663.555;D10.251.536
00000000|MMI|28.15|Bone Morphogenetic Proteins|C0053932|[aapp,bacs]|["BMP"-tx-27-"BMP"-noun-0,"BMP"-tx-26-"BMP"-noun-0]|TX|4814/3;4774/3|D12.644.276.954.200;D12.776.467.942.200;D23.529.942.200
00000000|MMI|27.98|Ivory Coast|C0022326|[geoa]|["IV"-tx-25-"IV"-noun-0,"IV"-tx-13-"IV"-noun-0]|TX|4702/2;3236/2|Z01.058.290.190.272
00000000|MMI|27.94|Saint Kitts and Nevis|C0282380|[geoa]|["SC"-tx-10-"SC"-noun-0,"SC"-tx-2-"SC"-noun-0]|TX|2187/2;541/2|Z01.107.084.900.787;Z01.639.880.787
00000000|MMI|27.92|Patent ductus arteriosus|C0013274|[cgab]|["PDA"-tx-17-"PDA"-noun-0,"PDA"-tx-13-"PDA"-noun-0]|TX|3875/3;3405/3|C14.240.400.340;C14.280.400.340;C16.131.240.400.340
00000000|MMI|26.35|Disease|C0012634|[dsyn]|["condition"-tx-48-"CONDITION"-noun-0,"condition"-tx-35-"condition"-noun-0,"condition"-tx-13-"Conditions"-noun-0]|TX|6560/9;5318/9;2769/10|C23.550.288
00000000|MMI|26.20|Dialysis procedure|C0011946|[topp]|["Dialysis"-tx-36-"dialysis"-noun-0,"Dialysis"-tx-35-"dialysis"-noun-0,"Dialysis"-tx-30-"dialysis"-noun-0]|TX|5432/8;5330/8;5040/8|E02.870.300;E02.912.800
00000000|MMI|24.87|Obesity|C0028754|[dsyn]|["OBESE"-tx-20-"obese"-adj-0]|TX|4203/5|C18.654.726.500;C23.888.144.699.500;E01.370.600.115.100.160.120.699.500;G07.100.100.160.120.699.500
00000000|MMI|23.93|Educational process of instructing|C0039401|[edac]|["Instruction"-tx-10-"Instruction"-noun-0,"Instruction"-tx-9-"Instruction"-noun-0,"Instruction"-tx-5-"Instruction"-noun-0,"Instruction"-tx-2-"Instruction"-noun-0]|TX|1864/11;1691/11;1387/11;884/11|I02.903
00000000|MMI|23.62|Calcitriol|C0006674|[orch,phsu,vita]|["CALCITRIOL"-tx-2-"CALCITRIOL"-noun-0]|TX|396/10|D04.808.247.222.159.478.387.300;D04.808.247.808.146.478.387.300;D04.808.812.768.196.478.387.300;D10.570.938.146.478.387.300
00000000|MMI|23.62|Epoetin Alfa|C0357126|[aapp,phsu]|["Epoetin Alfa"-tx-2-"EPOETIN ALFA"-noun-0]|TX|511/12|D12.644.276.374.410.240.150.500;D12.776.395.240.150.750;D12.776.467.374.410.240.150.500;D23.529.374.410.240.150.750
00000000|MMI|23.62|Heme|C0018966|[bacs,orch]|["Haem"-tx-40-"HEME"-noun-0]|TX|5755/4|D03.383.129.578.840.500.640.587;D03.549.909.500.640.587;D04.345.783.500.640.587;D23.767.727.640.587
00000000|MMI|23.62|Weight Gain|C0043094|[fndg]|["Gain, Weight"-tx-28-"weight gain"-noun-0]|TX|4884/11|C23.888.144.243.926;G07.700.320.249.314.120.200.926
00000000|MMI|23.28|To|C1883351|[qlco]|["To"-tx-44-"to"-adv-0,"To"-tx-41-"to"-adv-0,"To"-tx-28-"to"-adv-0,"To"-tx-21-"to"-adv-0,"To"-tx-3-"to"-adv-0]|TX|6326/2;5843/2;4876/2;4413/2;1034/2|
00000000|MMI|23.05|Diabetes Mellitus|C0011849|[dsyn]|["DIABETES MELLITUS"-tx-13-"diabetes mellitus"-noun-0,"Diabetes"-tx-13-"diabetes"-noun-0]|TX|2847/17;2836/8|C18.452.394.750;C19.246
00000000|MMI|23.02|Infantile Neuroaxonal Dystrophy|C0270724|[dsyn]|["PLAN"-tx-48-"PLAN"-noun-0,"PLAN"-tx-39-"plan"-verb-0]|TX|6584/4;5585/4|C10.228.140.744
00000000|MMI|22.72|Costa Rica|C0010182|[geoa]|["CRI"-tx-31-"CRI"-noun-0,"CRI"-tx-13-"CRI"-noun-0]|TX|5157/3;3333/3|Z01.107.169.238
00000000|MMI|22.67|Stomach|C0038351|[bpoc]|["STOMACH"-tx-10-"stomach"-noun-0,"STOMACH"-tx-2-"stomach"-noun-0]|TX|1893/7;937/7|A03.556.875.875
00000000|MMI|22.57|Diurese|C0719972|[orch,phsu]|["Diurese"-tx-30-"diuresed"-verb-0]|TX|5014/8|D02.886.590.700.135.261.476.716;D02.886.655.500.261.476.716;D03.438.174.261.476.716
00000000|MMI|22.54|Rabbi|C0684010|[prog]|["R."-tx-20-"R"-noun-0,"R."-tx-13-"R"-noun-0]|TX|4178/1;3231/1|M01.526.799.500
00000000|MMI|22.51|Awareness|C0004448|[menp]|["Aware"-tx-9-"aware"-adj-0,"Aware"-tx-5-"aware"-adj-0]|TX|1609/5;1334/5|F02.463.188.150
00000000|MMI|22.45|GZMA protein, human|C1313497|[aapp,enzy]|["HF"-tx-24-"HF"-noun-0,"HF"-tx-21-"HF"-noun-0]|TX|4567/2;4449/2|x.x.x.x
00000000|MMI|22.45|Hafnium|C0018488|[elii]|["Hf"-tx-24-"HF"-noun-0,"Hf"-tx-21-"HF"-noun-0]|TX|4567/2;4449/2|D01.268.556.337;D01.268.956.249;D01.552.544.337;x.x.x.x
00000000|MMI|22.11|Peptide Elongation Factor 1|C0059036|[aapp,enzy]|["EF 1"-tx-18-"1 EF"-noun-0]|TX|3918/1,3925/2|D08.811.277.040.330.300.100.101;D12.776.157.325.150.101;D12.776.835.700.350.101
00000000|MMI|22.01|Override|C1547671|[acty]|["Override"-tx-9-"override"-verb-0,"Override"-tx-6-"Override"-verb-0,"Override"-tx-6-"overridden"-noun-0,"Override"-tx-5-"override"-verb-0,"Override"-tx-3-"Override"-verb-0]|TX|1599/8;1465/8;1453/10;1324/8;[1126/8],[1143/8]|
00000000|MMI|20.88|Insulin Glargine|C0907402|[aapp,horm,phsu]|["INSULIN GLARGINE"-tx-10-"INSULIN GLARGINE"-noun-0]|TX|2159/16|D06.472.699.587.200.300.100;D12.644.548.586.200.300.100
00000000|MMI|20.88|Pelizaeus-Merzbacher Disease|C0205711|[dsyn]|["PMD"-tx-11-"PMD"-noun-0]|TX|2470/3|C10.228.140.163.100.362.775;C10.228.140.695.625.775;C10.314.400.775;C16.320.322.906;C16.320.565.189.362.775;C18.452.132.100.362.775;C18.452.648.189.362.775
00000000|MMI|20.88|Surgical aspects|C0038895|[ftcn]|["operations"-tx-13-"OPERATIONS"-noun-0]|TX|3160/10|x.x.x.x.x.x.x
00000000|MMI|19.99|Hypertensive disease|C0020538|[dsyn]|["HTN"-tx-13-"htn"-noun-0,"HYPERTENSION"-tx-13-"hypertension"-noun-0]|TX|2867/3;2873/12|C14.907.489
00000000|MMI|19.75|Instruction [Publication Type]|C0302828|[inpr]|["Instruction"-tx-10-"Instruction"-noun-0,"instructions"-tx-10-"Instructions"-noun-0,"Instruction"-tx-9-"Instruction"-noun-0,"Instruction"-tx-5-"Instruction"-noun-0,"instructions"-tx-3-"Instructions"-noun-0,"Instruction"-tx-2-"Instruction"-noun-0]|TX|1864/11;2214/12;1691/11;1387/11;1014/12;884/11|
00000000|MMI|19.75|Instructions|C1442085|[idcn]|["Instructions"-tx-10-"Instructions"-noun-0,"instruction"-tx-10-"Instruction"-noun-0,"instruction"-tx-9-"Instruction"-noun-0,"instruction"-tx-5-"Instruction"-noun-0,"Instructions"-tx-3-"Instructions"-noun-0,"instruction"-tx-2-"Instruction"-noun-0]|TX|2214/12;1864/11;1691/11;1387/11;1014/12;884/11|
00000000|MMI|19.50|Walking (activity)|C0080331|[dora]|["Walk"-tx-15-"walk"-verb-0]|TX|3718/4|G11.427.590.530.568.900;G11.427.590.530.698.277.937;I03.350.937;I03.450.642.845.940
00000000|MMI|19.43|Kidney Failure, Chronic|C0022661|[dsyn]|["CHRONIC RENAL FAILURE"-tx-2-"Chronic Renal Failure"-noun-0]|TX|689/21|C12.777.419.780.750.500;C13.351.968.419.780.750.500
00000000|MMI|19.40|Body Weight|C0005910|[orga]|["Weight"-tx-10-"weight"-noun-0]|TX|2382/6|C23.888.144;E01.370.600.115.100.160.120;E05.041.124.160.750;G07.100.100.160.120;G07.700.320.249.314.120
00000000|MMI|19.34|/40|C0439509|[tmco]|["/40"-tx-44-"40"-integer-0,"/40"-tx-17-"40"-percentage-0,"/40"-tx-10-"40"-integer-0,"/40"-tx-1-"40"-integer-0]|TX|[6151/2],[6174/2];[3885/2],[3895/2];2273/2;78/2|
00000000|MMI|19.34|40%|C3842587|[qnco]|["40%"-tx-44-"40"-integer-0,"40%"-tx-17-"40"-percentage-0,"40%"-tx-10-"40"-integer-0,"40%"-tx-1-"40"-integer-0]|TX|[6151/2],[6174/2];[3885/2],[3895/2];2273/2;78/2|
00000000|MMI|19.27|Infusion pump Alert priority PM|C4049155|[fndg]|["PM"-tx-51-"PM"-noun-0,"PM"-tx-49-"pm"-adj-0,"PM"-tx-13-"pm"-adj-0,"PM"-tx-12-"pm"-adj-0,"PM"-tx-11-"pm"-adj-0,"PM"-tx-1-"PM"-adj-0]|TX|6774/2;6681/2;2586/2;2537/2;2490/2;147/2|
00000000|MMI|18.94|Magnesium Cation|C2346927|[elii,phsu]|["Mg++"-tx-10-"MG"-noun-0,"Mg++"-tx-9-"MG"-noun-0,"Mg++"-tx-3-"MG"-noun-0]|TX|[1791/2],[2019/2],[2099/2],[2140/2];1641/2;1058/2|
00000000|MMI|18.94|Milligram percent|C1960952|[qnco]|["mg %"-tx-10-"MG"-noun-0,"mg %"-tx-9-"MG"-noun-0,"mg %"-tx-3-"MG"-noun-0]|TX|[1791/2],[2019/2],[2099/2],[2140/2];1641/2;1058/2|
00000000|MMI|18.94|mg/dL|C0439269|[qnco]|["mg%"-tx-10-"MG"-noun-0,"mg%"-tx-9-"MG"-noun-0,"mg%"-tx-3-"MG"-noun-0]|TX|[1791/2],[2019/2],[2099/2],[2140/2];1641/2;1058/2|
00000000|MMI|18.36|Doctor of Medicine|C1512018|[inpr]|["M.D."-tx-50-"M.D"-noun-0,"M.D."-tx-7-"M.D"-noun-0,"M.D."-tx-4-"M.D"-noun-0,"M.D."-tx-1-"M.D"-noun-0]|TX|6743/3;1514/3;1192/3;269/3|
00000000|MMI|18.36|Hold (action)|C1948035|[acty]|["Hold"-tx-10-"HOLD"-verb-0,"Hold"-tx-9-"HOLD"-verb-0,"Hold"-tx-3-"HOLD"-verb-0,"Hold"-tx-2-"HOLD"-verb-0]|TX|1823/4;1650/4;969/4;831/4|
00000000|MMI|18.36|Hold - dosing instruction fragment|C1553387|[idcn]|["Hold"-tx-10-"HOLD"-verb-0,"Hold"-tx-9-"HOLD"-verb-0,"Hold"-tx-3-"HOLD"-verb-0,"Hold"-tx-2-"HOLD"-verb-0]|TX|1823/4;1650/4;969/4;831/4|
00000000|MMI|18.36|hold - Data Operation|C3853841|[ftcn]|["hold"-tx-10-"HOLD"-verb-0,"hold"-tx-9-"HOLD"-verb-0,"hold"-tx-3-"HOLD"-verb-0,"hold"-tx-2-"HOLD"-verb-0]|TX|1823/4;1650/4;969/4;831/4|
00000000|MMI|18.15|Flovent|C0720466|[orch,phsu]|["Flovent"-tx-10-"FLOVENT"-noun-0]|TX|1939/7|D04.808.054.079.129.114
00000000|MMI|18.15|Furosemide|C0016860|[orch,phsu]|["FUROSEMIDE"-tx-2-"FUROSEMIDE"-noun-0]|TX|751/10|D02.065.884.725.300;D02.092.146.807.300;D02.886.590.700.725.300
00000000|MMI|18.15|Uncertainty|C0087130|[fndg]|["Uncertain"-tx-36-"uncertain"-adj-0]|TX|5404/9|E05.318.740.600.900;F02.463.785.373.820;G17.680.875;N05.715.360.750.625.850;N06.850.520.830.600.900
00000000|MMI|17.46|Time|C0040223|[tmco]|["TIME"-tx-37-"time"-noun-0,"TIME"-tx-30-"time"-noun-0,"TIME"-tx-2-"time"-noun-0]|TX|5467/4;4969/4;609/4|G01.910
00000000|MMI|17.45|Ischemia|C0022116|[patf]|["Ischaemia, NOS"-tx-21-"ISCHEMIA"-noun-0,"Ischaemia, NOS"-tx-21-"ischemia"-noun-0]|TX|4359/8;4423/8|C23.550.513
00000000|MMI|17.27|Veins|C0042449|[bpoc]|["VEIN"-tx-36-"vein"-noun-0,"VEIN"-tx-13-"vein"-noun-0]|TX|5375/4;3251/4|A07.231.908
00000000|MMI|17.20|Appointments|C0003629|[idcn]|["Appointment"-tx-49-"appointment"-noun-0,"Appointment"-tx-10-"APPOINTMENT"-noun-0]|TX|6653/11;2439/11|N04.452.095
00000000|MMI|17.05|Stent, device|C0038257|[medd]|["Stent"-tx-21-"stent"-noun-0,"Stent"-tx-13-"stent"-noun-0]|TX|4387/5;3396/5|E07.695.750
00000000|MMI|16.98|Sao Tome and Principe|C0036183|[geoa]|["TP"-tx-3-"TP"-noun-0,"TP"-tx-2-"TP"-noun-0]|TX|1007/2;492/2|Z01.639.040
00000000|MMI|16.81|Nuchal Translucency Screen|C1449832|[diap]|["NT"-tx-20-"NT"-noun-0]|TX|4211/2|E01.370.350.850.865.500;E01.370.378.630.865.500
00000000|MMI|16.77|Meal (occasion for eating)|C1998602|[dora]|["Meals"-tx-2-"meals"-noun-0]|TX|919/5|F01.145.407.432.500;F01.145.466.349.500;G07.203.300.590;G07.203.650.353.432.500;J02.500.590
00000000|MMI|16.76|Echocardiography, Stress|C0920208|[diap]|["Stress Echo"-tx-18-"Stress echo"-noun-0]|TX|3900/11|E01.370.350.130.750.228;E01.370.350.850.220.228;E01.370.370.380.220.228
00000000|MMI|16.72|District of Columbia|C0012764|[geoa]|["D.C."-tx-1-"D/C"-noun-0]|TX|185/3|Z01.107.567.875.500.210;Z01.433.429
00000000|MMI|16.69|Chronic Kidney Diseases|C1561643|[dsyn]|["Chronic Renal Failure"-tx-2-"Chronic Renal Failure"-noun-0]|TX|689/21|C12.777.419.780.750;C13.351.968.419.780.750
00000000|MMI|16.65|Clonidine Hydrochloride|C0546860|[orch,phsu]|["clonidine hcl"-tx-2-"CLONIDINE HCL"-noun-0]|TX|467/13|D03.383.129.308.436.500
00000000|MMI|16.65|Choline O-Acetyltransferase|C0008407|[aapp,enzy]|["CHAT"-tx-1-"Chat"-noun-0]|TX|90/4|D08.811.913.050.134.180
00000000|MMI|16.53|Lymphotoxin-Alpha, human|C3887647|[aapp,imft]|["LT"-tx-10-"lt"-noun-0,"LT"-tx-9-"lt"-noun-0,"LT"-tx-3-"lt"-noun-0,"LT"-tx-2-"lt"-noun-0]|TX|1836/2;1663/2;982/2;[844/2],[856/2]|
00000000|MMI|16.53|Structure of left thigh|C0230426|[bpoc]|["LT"-tx-10-"lt"-noun-0,"LT"-tx-9-"lt"-noun-0,"LT"-tx-3-"lt"-noun-0,"LT"-tx-2-"lt"-noun-0]|TX|1836/2;1663/2;982/2;[844/2],[856/2]|
00000000|MMI|16.35|Order (action)|C1705178|[acty]|["Order"-tx-51-"ORDERS"-verb-0,"Order"-tx-4-"order"-noun-0,"Order"-tx-2-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|6801/6;1200/5;617/5;189/5;43/6|
00000000|MMI|16.35|Order (arrangement)|C1705176|[qlco]|["Order"-tx-51-"ORDERS"-verb-0,"Order"-tx-4-"order"-noun-0,"Order"-tx-2-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|6801/6;1200/5;617/5;189/5;43/6|
00000000|MMI|16.35|Order (document)|C1705175|[inpr]|["Order"-tx-51-"ORDERS"-verb-0,"Order"-tx-4-"order"-noun-0,"Order"-tx-2-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|6801/6;1200/5;617/5;189/5;43/6|
00000000|MMI|16.35|Order (taxonomic)|C1705177|[clas]|["Order"-tx-51-"ORDERS"-verb-0,"Order"-tx-4-"order"-noun-0,"Order"-tx-2-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|6801/6;1200/5;617/5;189/5;43/6|
00000000|MMI|16.35|Permutation|C1882348|[qlco]|["Order"-tx-51-"ORDERS"-verb-0,"Order"-tx-4-"order"-noun-0,"Order"-tx-2-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|6801/6;1200/5;617/5;189/5;43/6|
00000000|MMI|16.35|Sequence of Planned Assessment Schedule|C3889825|[inpr]|["ORDER"-tx-51-"ORDERS"-verb-0,"ORDER"-tx-4-"order"-noun-0,"ORDER"-tx-2-"order"-noun-0,"ORDER"-tx-1-"ORDER"-noun-0,"ORDER"-tx-1-"ORDERS"-verb-0]|TX|6801/6;1200/5;617/5;189/5;43/6|
00000000|MMI|16.34|10%|C3842590|[fndg]|["10%"-tx-20-"10"-integer-0,"10%"-tx-13-"10"-fraction-0,"10%"-tx-9-"10"-integer-0,"10%"-tx-2-"10"-integer-0,"10%"-tx-1-"10"-fraction-0]|TX|4055/2;3414/2;1638/2;526/2;18/2|
00000000|MMI|16.29|Body Fluid Discharge|C0012621|[bdsu]|["Discharge"-tx-51-"DISCHARGE"-noun-0,"Discharge"-tx-48-"DISCHARGE"-noun-0,"Discharge"-tx-13-"DISCHARGE"-noun-0,"Discharge"-tx-2-"DISCHARGE"-verb-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|6791/9;6550/9;2667/9;327/9;33/9|
00000000|MMI|16.29|Discharge, body substance|C2926602|[bdsu]|["Discharge"-tx-51-"DISCHARGE"-noun-0,"Discharge"-tx-48-"DISCHARGE"-noun-0,"Discharge"-tx-13-"DISCHARGE"-noun-0,"Discharge"-tx-2-"DISCHARGE"-verb-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|6791/9;6550/9;2667/9;327/9;33/9|
00000000|MMI|15.92|90%|C3842582|[fndg]|["90%"-tx-19-"90"-fraction-0,"90%"-tx-10-"90"-integer-0,"90%"-tx-9-"90"-integer-0,"90%"-tx-2-"90"-integer-0,"90%"-tx-1-"90"-integer-0]|TX|3979/2;1839/2;1666/2;847/2;81/2|
00000000|MMI|15.92|<90|C0439087|[qnco]|["<90"-tx-19-"90"-fraction-0,"<90"-tx-10-"90"-integer-0,"<90"-tx-9-"90"-integer-0,"<90"-tx-2-"90"-integer-0,"<90"-tx-1-"90"-integer-0]|TX|3979/2;1839/2;1666/2;847/2;81/2|
00000000|MMI|15.92|>90|C0439083|[qnco]|[">90"-tx-19-"90"-fraction-0,">90"-tx-10-"90"-integer-0,">90"-tx-9-"90"-integer-0,">90"-tx-2-"90"-integer-0,">90"-tx-1-"90"-integer-0]|TX|3979/2;1839/2;1666/2;847/2;81/2|
00000000|MMI|15.42|Amlodipine|C0051696|[orch,phsu]|["AMLODIPINE"-tx-9-"AMLODIPINE"-noun-0]|TX|1625/10|D03.383.725.203.065
00000000|MMI|15.42|Chest Pain|C0008031|[sosy]|["CHEST PAIN"-tx-45-"chest pain"-noun-0]|TX|6398/10|C10.597.617.192;C23.888.592.612.233
00000000|MMI|15.42|Coronary Arteriosclerosis|C0010054|[dsyn]|["coronary artery disease"-tx-13-"coronary artery disease"-noun-0]|TX|3092/23|C14.280.647.250.260;C14.907.137.126.339;C14.907.585.250.260
00000000|MMI|15.42|Coronary Artery Disease|C1956346|[dsyn]|["CORONARY ARTERY DISEASE"-tx-13-"coronary artery disease"-noun-0]|TX|3092/23|C14.280.647.250.260;C14.907.137.126.339;C14.907.585.250.260
00000000|MMI|15.42|In Blood|C0005768|[bdsu]|["BLOOD"-tx-49-"blood"-noun-0]|TX|6616/5|x.x.x.x.x
00000000|MMI|14.12|Diuretics|C0012798|[phsu]|["DIURETICS"-tx-13-"diuretics"-noun-0]|TX|3239/9|D27.505.696.560.500
00000000|MMI|14.12|Norvasc|C0162712|[orch,phsu]|["Norvasc"-tx-9-"NORVASC"-noun-0]|TX|1615/7|D03.383.725.203.065
00000000|MMI|14.04|Time Studies|C0040227|[inpr]|["Time Studies"-tx-41-"studies time"-noun-0]|TX|5854/7,5870/4|F02.784.412.846.707;F02.784.692.746.707
00000000|MMI|13.99|Central African Republic|C0007673|[geoa]|["CT"-tx-43-"CT"-noun-0]|TX|5966/2|Z01.058.290.100.120
00000000|MMI|13.96|Isosorbide|C0022251|[orch,phsu]|["ISOSORBIDE"-tx-10-"ISOSORBIDE"-noun-0]|TX|1759/10|D02.033.800.813.480;D09.853.813.480
00000000|MMI|13.93|Lisinopril|C0065374|[aapp,phsu]|["Lysinopril"-tx-44-"Lisinopril"-noun-0]|TX|6159/10|D12.644.456.345.600
00000000|MMI|13.90|Guaiac|C0018302|[irda,orch]|["GUAIAC"-tx-40-"Guaiac"-noun-0]|TX|5630/6|D20.215.721.500.490
00000000|MMI|13.90|Age of Onset|C0206132|[qnco]|["Onset"-tx-14-"onset"-noun-0]|TX|3656/5|N05.715.350.075.100;N06.850.490.250.100
00000000|MMI|13.90|Hemoglobin|C0019046|[aapp,bacs]|["Hgb"-tx-2-"Hgb"-noun-0]|TX|596/3|D12.776.124.400;D12.776.422.316.762
00000000|MMI|13.89|Fluorides|C0016327|[inch,phsu]|["F-"-tx-43-"f"-noun-0]|TX|5962/1|D01.248.497.158.380;D01.303.350.300
00000000|MMI|13.89|Poverty|C0032854|[grpa]|["Poor"-tx-43-"poor"-adj-0]|TX|5949/4|I01.880.735.634;I01.880.853.996.535;N01.824.600
00000000|MMI|13.86|isoniazid|C0022209|[orch,phsu]|["ISONIAZID"-tx-10-"INH"-noun-0]|TX|2310/3|D02.442.436;D03.066.349.410;D03.383.725.394.582
00000000|MMI|13.63|Diagnosis|C0011900|[fndg]|["DIAGNOSIS"-tx-13-"DIAGNOSIS"-noun-0,"DIAGNOSIS"-tx-2-"Diagnosis"-noun-0]|TX|[2621/9],[2759/9];678/9|E01
00000000|MMI|13.63|Diagnosis Study|C1704656|[resa]|["DIAGNOSIS"-tx-13-"DIAGNOSIS"-noun-0,"DIAGNOSIS"-tx-2-"Diagnosis"-noun-0]|TX|[2621/9],[2759/9];678/9|
00000000|MMI|12.97|Delayed Release Dosage Form|C1707664|[bodm]|["DR"-tx-44-"Dr"-noun-0,"DR"-tx-12-"Dr"-noun-0,"DR"-tx-11-"Dr"-noun-0,"DR"-tx-10-"Dr"-noun-0]|TX|6294/2;2552/2;2505/2;2457/2|
00000000|MMI|12.97|Device to Subject Relationship Domain|C3540849|[inpr]|["DR"-tx-44-"Dr"-noun-0,"DR"-tx-12-"Dr"-noun-0,"DR"-tx-11-"Dr"-noun-0,"DR"-tx-10-"Dr"-noun-0]|TX|6294/2;2552/2;2505/2;2457/2|
00000000|MMI|12.97|Doctor - Title|C2348314|[cnce]|["Dr."-tx-44-"Dr"-noun-0,"Dr."-tx-12-"Dr"-noun-0,"Dr."-tx-11-"Dr"-noun-0,"Dr."-tx-10-"Dr"-noun-0]|TX|6294/2;2552/2;2505/2;2457/2|
00000000|MMI|12.79|Hospital admission|C0184666|[hlca]|["Admission"-tx-34-"admission"-noun-0,"Admission"-tx-14-"admission"-noun-0,"Admission"-tx-13-"Admission"-noun-0,"Admit"-tx-13-"ADMIT"-verb-0]|TX|5268/9;3548/9;2724/9;2615/5|
00000000|MMI|12.77|Code|C0805701|[inpr]|["CODE"-tx-44-"CODE"-verb-0,"CODE"-tx-44-"Code"-noun-0,"CODE"-tx-2-"CODE"-noun-0,"CODE"-tx-2-"code"-noun-0]|TX|6027/4;6022/4;274/4;292/4|
00000000|MMI|12.77|eTMF Content Model Code|C3889831|[inpr]|["Code"-tx-44-"CODE"-verb-0,"Code"-tx-44-"Code"-noun-0,"Code"-tx-2-"CODE"-noun-0,"Code"-tx-2-"code"-noun-0]|TX|6027/4;6022/4;274/4;292/4|
00000000|MMI|12.69|ANOPHTHALMIA AND PULMONARY HYPOPLASIA|C1832661|[dsyn]|["PMD"-tx-11-"PMD"-noun-0]|TX|2470/3|x.x.x.x
00000000|MMI|12.69|Chronic disease|C0008679|[dsyn]|["Chronic Disease"-tx-41-"chronic disease"-noun-0]|TX|5788/15|C23.550.291.500
00000000|MMI|12.69|Coronary heart disease|C0010068|[dsyn]|["Coronary (artery) disease"-tx-13-"coronary artery disease"-noun-0]|TX|3092/23|C14.280.647.250;C14.907.585.250
00000000|MMI|12.69|Diet|C0012155|[food]|["Diet"-tx-10-"DIET"-noun-0]|TX|2353/4|G07.203.650.240
00000000|MMI|12.69|Endometriosis|C0014175|[dsyn]|["Endo"-tx-40-"ENDO"-adj-0]|TX|5651/4|C13.351.500.163
00000000|MMI|12.69|Iron-Refractory Iron Deficiency Anemia|C0085576|[dsyn]|["Microcytic anaemia"-tx-40-"microcytic anemia"-noun-0]|TX|5761/17|x.x.x.x
00000000|MMI|12.69|Kidney Diseases|C0022658|[dsyn]|["RENAL DISEASE, NOS"-tx-2-"Renal Disease"-noun-0]|TX|571/13|C12.777.419;C13.351.968.419
00000000|MMI|12.69|Panic|C0030318|[fndg]|["Panic"-tx-13-"panic"-noun-0]|TX|2916/5|F01.470.361.585
00000000|MMI|12.69|Rales|C0034642|[sosy]|["RALES"-tx-20-"Rales"-noun-0]|TX|4126/5|C23.888.852.779;E01.370.386.720;G09.772.775
00000000|MMI|12.69|Wheezing|C0043144|[sosy]|["WHEEZING"-tx-10-"Wheezing"-verb-0]|TX|2344/8|C23.888.852.779;E01.370.386.720;G09.772.775
00000000|MMI|12.69|calcium acetate|C0717537|[irda,orch,phsu]|["CALCIUM ACETATE"-tx-2-"CALCIUM ACETATE"-noun-0]|TX|435/15|x.x.x.x
00000000|MMI|12.69|clopidogrel|C0070166|[orch,phsu]|["CLOPIDOGREL"-tx-10-"CLOPIDOGREL"-noun-0]|TX|2082/11|x.x.x.x
00000000|MMI|12.69|lamotrigine|C0064636|[orch,phsu]|["LAMOTRIGINE"-tx-10-"LAMOTRIGINE"-noun-0]|TX|2001/11|x.x.x.x
00000000|MMI|12.69|oxcarbazepine|C0069751|[orch,phsu]|["OXCARBAZEPINE"-tx-10-"OXCARBAZEPINE"-noun-0]|TX|2120/13|x.x.x.x
00000000|MMI|12.69|pantoprazole|C0081876|[orch,phsu]|["PANTOPRAZOLE"-tx-10-"PANTOPRAZOLE"-noun-0]|TX|2258/12|x.x.x.x
00000000|MMI|12.52|+2|C0740116|[qnco]|["+2"-tx-47-"2"-real_number-0,"+2"-tx-24-"2"-integer-0,"+2"-tx-20-"2"-fraction-0,"+2"-tx-20-"2"-integer-0]|TX|6515/1;4538/1;[4105/1],[4227/1];[4105/1],[4227/1]|
00000000|MMI|12.52|2+|C3833492|[fndg]|["2+"-tx-47-"2"-real_number-0,"2+"-tx-24-"2"-integer-0,"2+"-tx-20-"2"-fraction-1,"2+"-tx-20-"2"-integer-0]|TX|6515/1;4538/1;[4105/1],[4227/1];[4105/1],[4227/1]|
00000000|MMI|12.52|2+ Score|C2827735|[qnco]|["2+"-tx-47-"2"-real_number-0,"2+"-tx-24-"2"-integer-0,"2+"-tx-20-"2"-fraction-0,"2+"-tx-20-"2"-integer-0]|TX|6515/1;4538/1;[4105/1],[4227/1];[4105/1],[4227/1]|
00000000|MMI|12.52|2+ Score, WHO|C2981700|[clas]|["2+"-tx-47-"2"-real_number-0,"2+"-tx-24-"2"-integer-0,"2+"-tx-20-"2"-fraction-0,"2+"-tx-20-"2"-integer-0]|TX|6515/1;4538/1;[4105/1],[4227/1];[4105/1],[4227/1]|
00000000|MMI|12.41|20%|C3842589|[fndg]|["20%"-tx-49-"20"-integer-0,"20%"-tx-19-"20"-integer-0,"20%"-tx-13-"20"-integer-0,"20%"-tx-2-"20"-fraction-0]|TX|6678/2;3998/2;2583/2;639/2|
00000000|MMI|12.15|Patients|C0030705|[podg]|["*^patient"-tx-30-"patient"-noun-0,"*^patient"-tx-10-"Patient"-noun-0]|TX|4974/7;2359/7|M01.643
00000000|MMI|11.47|Home visit (procedure)|C0020043|[hlca]|["home services"-tx-2-"Home services"-noun-0]|TX|310/4,318/8|N04.452.758.307
00000000|MMI|11.45|Activities of Daily Living (activity)|C0001288|[dora]|["Daily Activity"-tx-10-"daily ACTIVITY"-noun-0]|TX|2389/14|E02.831.067;I03.050;N02.421.784.110
00000000|MMI|11.34|Solomon Islands|C0037623|[geoa]|["BP"-tx-19-"BP"-noun-0]|TX|3972/2|Z01.639.760.590
00000000|MMI|11.30|PT-9|C0701437|[orch,phsu]|["PT 9"-tx-14-"Pt 9"-noun-0]|TX|3529/2,3546/1|D03.383.725.086
00000000|MMI|11.29|BaseLine dental cement|C0168634|[bodm]|["baseline"-tx-14-"baseline"-noun-0]|TX|3574/8|x.x.x.x
00000000|MMI|11.29|Diuresis|C0012797|[ortf]|["Diuresis"-tx-26-"diuresis"-noun-0]|TX|4778/8|G08.852.796.241
00000000|MMI|11.29|Shoulder|C0037004|[blor]|["Shoulders"-tx-16-"shoulders"-noun-0]|TX|3809/9|A01.378.800.750
00000000|MMI|11.28|Kyrgyzstan|C0022718|[geoa]|["KG"-tx-47-"kg"-noun-0]|TX|6506/2|Z01.252.100.450;Z01.586.200.450;Z01.586.950.450
00000000|MMI|11.26|Dilatation and Curettage|C0012358|[topp]|["D & C"-tx-1-"D/C"-noun-0]|TX|185/3|E04.157.310;E04.950.300.299
00000000|MMI|11.23|Agenesis of corpus callosum|C0175754|[cgab]|["ACC"-tx-29-"acc"-noun-1]|TX|4934/3|C10.500.034;C16.131.666.034;C23.300.008
00000000|MMI|11.23|Aplasia Cutis Congenita|C0282160|[cgab,dsyn]|["ACC"-tx-29-"acc"-noun-1]|TX|4934/3|C16.131.077.350;C16.131.831.350;C16.320.850.250;C17.800.804.350;C17.800.827.250
00000000|MMI|11.21|PO-1|C0297198|[orch]|["PO-1"-tx-2-"PO 1"-noun-0]|TX|460/2,483/1|x.x.x.x
00000000|MMI|11.20|Leg|C1140621|[blor]|["LEG"-tx-13-"leg"-noun-0]|TX|3495/3|A01.378.610.500
00000000|MMI|11.19|DSP protein, human|C1531217|[aapp,bacs]|["DP"-tx-20-"DP"-noun-0]|TX|4252/2|x.x.x.x
00000000|MMI|11.18|Automobiles|C0004381|[mnob]|["Car"-tx-1-"CAR"-noun-0]|TX|104/3|J01.937.500.100
00000000|MMI|11.18|Rest|C0035253|[dora]|["Rest"-tx-16-"rest"-noun-0]|TX|3844/4|I03.450.769.647
00000000|MMI|11.17|Evaluation|C0220825|[hlca]|["Evaluation"-tx-1-"evaluation"-noun-0]|TX|169/10|E05.337;N05.715.360.335
00000000|MMI|11.17|Honduras|C0019905|[geoa]|["HO"-tx-1-"HO"-noun-0]|TX|166/2|Z01.107.169.534
00000000|MMI|11.16|Etiology|C1314792|[ftcn]|["Causes"-tx-43-"causes"-noun-0]|TX|5984/6|N05.715.350.200;N06.850.490.625
00000000|MMI|9.95|Bipolar Disorder|C0005586|[mobd]|["Bipolar Disease"-tx-13-"bipolar disease"-noun-0]|TX|2898/15|F03.084.500
00000000|MMI|9.95|Blood|C0005767|[tisu]|["Blood"-tx-49-"blood"-noun-0]|TX|6616/5|A12.207.152;A15.145
00000000|MMI|9.95|Complication Aspects|C1171258|[patf]|["complications"-tx-13-"Complications"-noun-0]|TX|2795/13|x.x.x
00000000|MMI|9.95|Diet therapy|C0012159|[hlca]|["Diet"-tx-10-"DIET"-noun-0]|TX|2353/4|E02.642.249
00000000|MMI|9.95|Fatigue|C0015672|[sosy]|["FATIGUE"-tx-2-"Fatigue"-noun-0]|TX|662/7|C23.888.369
00000000|MMI|9.95|Methods aspects|C0025664|[inpr]|["procedures"-tx-13-"PROCEDURES"-noun-0]|TX|3175/10|x.x.x
00000000|MMI|9.95|Panic Disorder|C0030319|[mobd]|["-- Panic Disorder"-tx-13-"panic disorder"-noun-0]|TX|2924/14|F03.080.700
00000000|MMI|9.77|1+|C3816745|[fndg]|["1+"-tx-48-"1"-integer-0,"1+"-tx-21-"1"-integer-0,"1+"-tx-3-"1"-integer-0]|TX|6590/1;4355/1;1114/1|
00000000|MMI|9.77|1+ Score|C2827734|[qnco]|["1+"-tx-48-"1"-integer-0,"1+"-tx-21-"1"-integer-0,"1+"-tx-3-"1"-integer-0]|TX|6590/1;4355/1;1114/1|
00000000|MMI|9.77|1+ Score, WHO|C2981698|[clas]|["1+"-tx-48-"1"-integer-0,"1+"-tx-21-"1"-integer-0,"1+"-tx-3-"1"-integer-0]|TX|6590/1;4355/1;1114/1|
00000000|MMI|9.76|Condition|C0348080|[qlco]|["Condition"-tx-48-"CONDITION"-noun-0,"Condition"-tx-35-"condition"-noun-0,"Condition"-tx-13-"Conditions"-noun-0]|TX|6560/9;5318/9;2769/10|
00000000|MMI|9.76|Condition:Find:Pt:^Patient:Nom|C3864998|[clna]|["Condition"-tx-48-"CONDITION"-noun-0,"Condition"-tx-35-"condition"-noun-0,"Condition"-tx-13-"Conditions"-noun-0]|TX|6560/9;5318/9;2769/10|
00000000|MMI|9.76|Logical Condition|C1705253|[cnce]|["Condition"-tx-48-"CONDITION"-noun-0,"Condition"-tx-35-"condition"-noun-0,"Condition"-tx-13-"Conditions"-noun-0]|TX|6560/9;5318/9;2769/10|
00000000|MMI|9.69|CALD1 wt Allele|C3813548|[gngm]|["CAD"-tx-21-"CAD"-noun-0,"CAD"-tx-13-"CAD"-noun-0,"CAD"-tx-13-"cad"-noun-0]|TX|4383/3;3327/3;3086/3|
00000000|MMI|9.65|Negation|C1518422|[ftcn]|["Not"-tx-29-"not"-adv-0,"Not"-tx-22-"not"-adv-0,"Not"-tx-13-"NOT"-adv-0]|TX|4924/3;4468/3;3222/3|
00000000|MMI|9.61|Genus Dialysis|C1059964|[euka]|["Dialysis"-tx-36-"dialysis"-noun-0,"Dialysis"-tx-35-"dialysis"-noun-0,"Dialysis"-tx-30-"dialysis"-noun-0]|TX|5432/8;5330/8;5040/8|
00000000|MMI|9.53|Bipolar|C0443156|[spco]|["Bipolar"-tx-43-"Bipolar"-adj-0,"Bipolar"-tx-13-"bipolar"-adj-0]|TX|5917/7;[2888/7],[3378/7]|
00000000|MMI|9.47|Give - dosing instruction imperative|C1947971|[ftcn]|["Given"-tx-35-"Given"-adj-0,"Give"-tx-10-"Give"-verb-0,"Give"-tx-10-"give"-verb-0]|TX|5299/5;1876/4;1903/4|
00000000|MMI|9.40|Indication of (contextual qualifier)|C0392360|[idcn]|["Reason"-tx-9-"Reason"-noun-0,"Reason"-tx-5-"Reason"-noun-0,"Reason"-tx-2-"Reason"-noun-0]|TX|1588/6;1313/6;550/6|
00000000|MMI|9.38|4+ Answer to question|C3838679|[fndg]|["4+"-tx-34-"4"-integer-0,"4+"-tx-10-"4"-integer-0,"4+"-tx-1-"4"-fraction-0]|TX|5263/1;2071/1;16/1|
00000000|MMI|9.37|Therapeutic procedure|C0087111|[topp]|["Treatment"-tx-13-"Treatment"-noun-0,"Therapeutic"-tx-3-"THERAPEUTIC"-adj-0,"Treatment"-tx-2-"Treatment"-noun-0]|TX|2821/9;1072/11;715/9|E02
00000000|MMI|9.35|Three times daily|C0556984|[tmco]|["TID"-tx-44-"tid"-noun-0,"TID"-tx-2-"TID"-noun-0]|TX|6254/3;[463/3],[827/3]|
00000000|MMI|9.35|three times a day at institution-specified times|C1610169|[tmco]|["TID"-tx-44-"tid"-noun-0,"TID"-tx-2-"TID"-noun-0]|TX|6254/3;[463/3],[827/3]|
00000000|MMI|9.32|Admission activity|C0809949|[hlca]|["Admission"-tx-34-"admission"-noun-0,"Admission"-tx-14-"admission"-noun-0,"Admission"-tx-13-"Admission"-noun-0]|TX|5268/9;3548/9;2724/9|
00000000|MMI|9.30|Before|C0332152|[tmco]|["BEFORE"-tx-49-"before"-adv-0,"Prior"-tx-21-"prior"-adj-0,"Prior to"-tx-14-"prior to"-prep-0]|TX|6628/6;4377/5;3639/8|
00000000|MMI|9.28|October|C3828732|[qlco]|["October"-tx-36-"October"-noun-0,"October"-tx-26-"October"-noun-0,"October"-tx-10-"October"-noun-0]|TX|5355/7;4746/7;1815/7|
00000000|MMI|9.27|Dose number:Number:Point in time:^Patient:Quantitative|C1114758|[clna]|["Dose #"-tx-40-"dose"-noun-0,"Dose #"-tx-10-"dose"-noun-0,"Dose number"-tx-10-"Number Doses"-noun-0]|TX|5674/4;2242/4;2029/6,2039/5|
00000000|MMI|9.19|Fluid overload|C0546817|[dsyn]|["VOLUME OVERLOAD"-tx-32-"volume overload"-noun-0,"VOLUME OVERLOAD"-tx-30-"volume overload"-noun-1,"VOLUME OVERLOAD"-tx-24-"volume overload"-noun-0]|TX|5188/15;5053/15;4675/15|
00000000|MMI|9.16|Time (foundation metadata concept)|C3541383|[tmco]|["Time"-tx-37-"time"-noun-0,"Time"-tx-30-"time"-noun-0,"Time"-tx-2-"time"-noun-0]|TX|5467/4;4969/4;609/4|
00000000|MMI|9.11|Schedule (document type)|C0086960|[inpr]|["Scheduled"-tx-13-"scheduled"-adj-0,"Scheduled"-tx-12-"scheduled"-adj-0,"Scheduled"-tx-11-"scheduled"-adj-0]|TX|2589/9;2540/9;2493/9|
00000000|MMI|9.11|Scheduled - priority|C1571999|[qlco]|["Scheduled"-tx-13-"scheduled"-adj-0,"Scheduled"-tx-12-"scheduled"-adj-0,"Scheduled"-tx-11-"scheduled"-adj-0]|TX|2589/9;2540/9;2493/9|
00000000|MMI|9.11|Scheduled - procedure status|C0205539|[qlco]|["Scheduled"-tx-13-"scheduled"-adj-0,"Scheduled"-tx-12-"scheduled"-adj-0,"Scheduled"-tx-11-"scheduled"-adj-0]|TX|2589/9;2540/9;2493/9|
00000000|MMI|9.05|100%|C3817553|[qnco]|["100%"-tx-25-"100"-integer-0,"100%"-tx-3-"100"-integer-0,"100%"-tx-2-"100"-integer-0]|TX|4711/3;985/3;764/3|
00000000|MMI|9.02|Beginning|C0439659|[tmco]|["Start"-tx-10-"Starting"-adj-0,"Start"-tx-2-"Starting"-noun-0]|TX|[1800/8],[2193/8];778/8|
00000000|MMI|9.02|Apply|C4048755|[ftcn]|["Apply"-tx-44-"apply"-verb-0,"Apply"-tx-3-"apply"-verb-0]|TX|6320/5;1028/5|
00000000|MMI|9.02|Apply (instruction)|C1879355|[ftcn]|["Apply"-tx-44-"apply"-verb-0,"Apply"-tx-3-"apply"-verb-0]|TX|6320/5;1028/5|
00000000|MMI|9.02|Digestive System Findings Domain|C3539617|[inpr]|["GI"-tx-40-"GI"-noun-0]|TX|[5607/2],[5611/2]|
00000000|MMI|9.02|GNAI1 wt Allele|C1708130|[gngm]|["Gi"-tx-40-"GI"-noun-0]|TX|[5607/2],[5611/2]|
00000000|MMI|9.02|GRAPEFRUIT EXTRACT|C0440280|[orch,phsu]|["GRAPEFRUIT"-tx-9-"grapefruit"-noun-0,"GRAPEFRUIT"-tx-5-"grapefruit"-noun-0]|TX|1709/10;1405/10|
00000000|MMI|9.02|Gastrointestinal studies and measurements|C4050121|[inpr]|["GI"-tx-40-"GI"-noun-0]|TX|[5607/2],[5611/2]|
00000000|MMI|9.02|Grapefruit (food)|C0995150|[food]|["GRAPEFRUIT"-tx-9-"grapefruit"-noun-0,"GRAPEFRUIT"-tx-5-"grapefruit"-noun-0]|TX|1709/10;1405/10|
00000000|MMI|9.02|Grapefruit Flavor|C1365950|[food]|["GRAPEFRUIT"-tx-9-"grapefruit"-noun-0,"GRAPEFRUIT"-tx-5-"grapefruit"-noun-0]|TX|1709/10;1405/10|
00000000|MMI|9.02|Imdur|C0590690|[orch,phsu]|["Imdur"-tx-44-"Imdur"-noun-0,"Imdur"-tx-10-"IMDUR"-noun-0]|TX|6182/5;1751/5|
00000000|MMI|9.02|VIT gene|C1421454|[gngm]|["VIT"-tx-8-"VIT"-noun-0,"VIT"-tx-4-"VIT"-noun-0]|TX|1561/3;1286/3|
00000000|MMI|9.02|Vitamin B3 Assay|C1142562|[lbpr]|["Niacin"-tx-8-"NIACIN"-noun-0,"Niacin"-tx-4-"NIACIN"-noun-0]|TX|1552/6;1277/6|
00000000|MMI|9.02|apply - action|C1632850|[ftcn]|["Apply"-tx-44-"apply"-verb-0,"Apply"-tx-3-"apply"-verb-0]|TX|6320/5;1028/5|
00000000|MMI|9.02|orders - HL7PublishingDomain|C3244315|[inpr]|["orders"-tx-51-"ORDERS"-verb-0,"orders"-tx-1-"ORDERS"-verb-0]|TX|6801/6;43/6|
00000000|MMI|8.91|Drawings (art)|C0013113|[inpr]|["Draw"-tx-49-"drawn"-verb-0]|TX|6622/5|V01.185.625;V02.700.300
00000000|MMI|8.59|Allergy Specialty|C0002111|[bmod]|["Allergy"-tx-13-"ALLERGY"-noun-0]|TX|2601/7|H02.403.044
00000000|MMI|8.57|Hemorrhage|C0019080|[patf]|["bleed"-tx-40-"bleed"-verb-0]|TX|5614/5|C23.550.414
00000000|MMI|8.47|Lower Extremity|C0023216|[blor]|["Leg"-tx-13-"leg"-noun-0]|TX|3495/3|A01.378.610
00000000|MMI|8.47|Tablet Dosage Form|C0039225|[bodm]|["TAB"-tx-3-"TAB"-noun-0]|TX|1116/3|D26.255.830
00000000|MMI|8.45|Blood Transfusion|C0005841|[topp]|["Transfusion"-tx-41-"transfusion"-noun-0]|TX|5814/11|E02.095.135
00000000|MMI|8.45|Food|C0016452|[food]|["Food"-tx-10-"food"-noun-0]|TX|1932/4|G07.203.300;J02.500
00000000|MMI|8.44|Hospitals|C0019994|[hcro,mnob]|["HOSPITAL"-tx-45-"hospital"-noun-0]|TX|6377/8|N02.278.421
00000000|MMI|8.43|Abdomen|C0000726|[blor]|["abd"-tx-20-"Abd"-noun-0]|TX|4191/3|A01.923.047
00000000|MMI|8.43|Males|C0086582|[orga]|["MALE"-tx-13-"male"-noun-0]|TX|3310/4|x.x.x
00000000|MMI|8.43|Body position|C1262869|[orga]|["POS"-tx-24-"poss"-noun-0]|TX|4660/4|G11.427.695
00000000|MMI|8.42|Cell Respiration|C0282636|[celf]|["oxygenation"-tx-43-"oxygenation"-noun-0]|TX|5999/11|G03.495.278;G04.299.305
00000000|MMI|8.42|Etiology aspects|C0015127|[ftcn]|["causes"-tx-43-"causes"-noun-0]|TX|5984/6|x.x.x
00000000|MMI|7.22|Infection|C3714514|[patf]|["Infections"-tx-13-"Infections"-noun-0]|TX|2782/10|C01.539
00000000|MMI|7.22|Measures|C0079809|[qnco]|["Measure"-tx-10-"measure"-verb-0]|TX|2374/7|E05.978
00000000|MMI|7.17|Make - Instruction Imperative|C1881534|[ftcn]|["Make"-tx-49-"Make"-verb-0,"Make"-tx-44-"made"-verb-0]|TX|6593/4;6078/4|
00000000|MMI|6.66|Abortion consent:Finding:Point in time:^Patient:Document|C2360836|[clna]|["Patient"-tx-30-"patient"-noun-0,"Patient"-tx-10-"Patient"-noun-0]|TX|4974/7;2359/7|
00000000|MMI|6.66|Hysterectomy consent:Finding:Point in time:^Patient:Document|C2360838|[clna]|["Patient"-tx-30-"patient"-noun-0,"Patient"-tx-10-"Patient"-noun-0]|TX|4974/7;2359/7|
00000000|MMI|6.66|Sterilization consent:Finding:Point in time:^Patient:Document|C2360840|[clna]|["Patient"-tx-30-"patient"-noun-0,"Patient"-tx-10-"Patient"-noun-0]|TX|4974/7;2359/7|
00000000|MMI|6.65|chest burning|C0740396|[sosy]|["chest burning"-tx-16-"Burning chest"-noun-0,"chest burning"-tx-13-"chest burning"-noun-0]|TX|3746/7,3757/5;3514/13|
00000000|MMI|6.55|Planned|C1301732|[ftcn]|["Plan"-tx-48-"PLAN"-noun-0,"Plan"-tx-39-"plan"-verb-0]|TX|6584/4;5585/4|
00000000|MMI|6.55|Treatment Plan|C0599880|[inpr]|["Plan"-tx-48-"PLAN"-noun-0,"Plan"-tx-39-"plan"-verb-0]|TX|6584/4;5585/4|
00000000|MMI|6.51|Adult female goat|C3668950|[mamm]|["Doe"-tx-15-"DOE"-noun-0,"Doe"-tx-13-"DOE"-noun-0]|TX|3726/3;3461/3|
00000000|MMI|6.51|Department of Energy|C1511776|[prog]|["DOE"-tx-15-"DOE"-noun-0,"DOE"-tx-13-"DOE"-noun-0]|TX|3726/3;3461/3|
00000000|MMI|6.51|Dyspnea on exertion|C0231807|[sosy]|["DOE"-tx-15-"DOE"-noun-0,"DOE"-tx-13-"DOE"-noun-0]|TX|3726/3;3461/3|
00000000|MMI|6.51|Past|C1444637|[tmco]|["Past"-tx-40-"past"-noun-0,"Past"-tx-26-"past"-noun-0]|TX|5623/4;4790/4|
00000000|MMI|6.48|Mapping (action)|C1283195|[acty]|["Mapping"-tx-36-"mapping"-noun-0,"Mapping"-tx-13-"mapping"-verb-0]|TX|5380/7;3262/7|
00000000|MMI|6.46|Ferric|C2346593|[elii]|["Fe+++"-tx-41-"FE"-noun-0]|TX|[5781/2],[5851/2]|
00000000|MMI|6.40|January|C3829466|[qlco]|["January"-tx-13-"January"-noun-0,"January"-tx-11-"January"-noun-0]|TX|2571/7;2476/7|
00000000|MMI|6.37|Chronic obstructive pulmonary disease of horses|C3714496|[dsyn]|["COPD"-tx-13-"COPD"-noun-0,"COPD"-tx-13-"copd"-noun-0]|TX|3360/4;3039/4|
00000000|MMI|6.34|Shortness of breath:-:Point in time:^Patient:-|C2707305|[clna]|["Shortness of breath"-tx-45-"shortness of breath"-noun-0,"Shortness of breath"-tx-10-"Shortness of Breath"-noun-0]|TX|6422/19;2322/19|
00000000|MMI|6.33|Blood group antibody I|C0221138|[aapp,imft]|["I NOS"-tx-29-"I"-noun-0,"I NOS"-tx-25-"I"-noun-0]|TX|4897/1;4730/1|
00000000|MMI|6.33|MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME|C3280240|[dsyn]|["MEDS"-tx-43-"meds"-noun-0,"MEDS"-tx-22-"meds"-noun-0]|TX|5935/4;4458/4|
00000000|MMI|6.33|Weight|C0043100|[qnco]|["WEIGHTS"-tx-25-"weights"-noun-0,"WEIGHT"-tx-10-"weight"-noun-0]|TX|4737/7;2382/6|
00000000|MMI|6.32|Interaction|C1704675|[ftcn]|["Interaction"-tx-8-"INTERACTION"-noun-0,"Interaction"-tx-4-"INTERACTION"-noun-0]|TX|1539/11;1264/11|
00000000|MMI|6.32|Plavix|C0633084|[orch,phsu]|["Plavix"-tx-22-"Plavix"-noun-0,"Plavix"-tx-10-"PLAVIX"-noun-0]|TX|4475/6;2073/6|
00000000|MMI|6.31|Biospecimen Domain|C3814390|[inpr]|["BS"-tx-20-"BS"-noun-0]|TX|[4152/2],[4217/2]|
00000000|MMI|6.31|Black Swiss Mouse|C4049076|[mamm]|["BS"-tx-20-"BS"-noun-0]|TX|[4152/2],[4217/2]|
00000000|MMI|6.31|Bug Search Subtest (WPPSI-IV)|C4050217|[inpr]|["BS"-tx-20-"BS"-noun-0]|TX|[4152/2],[4217/2]|
00000000|MMI|6.30|Hospital course|C0489547|[fndg]|["Hospital course"-tx-21-"Hospital Course"-noun-0,"Hospital course"-tx-13-"HOSPITAL COURSE"-noun-0]|TX|4324/15;3286/15|
00000000|MMI|6.30|Hospital course:Finding:Point in time:^Patient:Narrative|C0488549|[clna]|["Hospital course"-tx-21-"Hospital Course"-noun-0,"Hospital course"-tx-13-"HOSPITAL COURSE"-noun-0]|TX|4324/15;3286/15|
00000000|MMI|6.30|Entire vein|C1278960|[bpoc]|["Vein"-tx-36-"vein"-noun-0,"Vein"-tx-13-"vein"-noun-0]|TX|5375/4;3251/4|
00000000|MMI|6.28|Summary (document)|C1706244|[inpr]|["Summary"-tx-50-"summary"-noun-0,"Summary"-tx-1-"SUMMARY"-noun-0]|TX|6697/7;214/7|
00000000|MMI|6.28|summary - ActRelationshipSubset|C1552616|[inpr]|["summary"-tx-50-"summary"-noun-0,"summary"-tx-1-"SUMMARY"-noun-0]|TX|6697/7;214/7|
00000000|MMI|6.26|Complete Response with Incomplete Bone Marrow Recovery|C3538993|[fndg]|["CRi"-tx-31-"CRI"-noun-1,"CRi"-tx-13-"CRI"-noun-0]|TX|5157/3;3333/3|
00000000|MMI|6.26|Cranial Rhythmic Impulse|C1704519|[phsf]|["CRI"-tx-31-"CRI"-noun-1,"CRI"-tx-13-"CRI"-noun-0]|TX|5157/3;3333/3|
00000000|MMI|6.26|Endocrine System Findings Domain|C3538926|[idcn]|["ED"-tx-41-"ED"-noun-0,"ED"-tx-40-"ED"-noun-0]|TX|5831/2;5644/2|
00000000|MMI|6.26|RNH1 gene|C1826843|[gngm]|["CRI"-tx-31-"CRI"-noun-0,"CRI"-tx-13-"CRI"-noun-0]|TX|5157/3;3333/3|
00000000|MMI|6.26|S prime|C2603362|[clna]|["S'"-tx-13-"s"-prep-0,"S'"-tx-10-"("-noun-0]|TX|3392/1;2450/1|
00000000|MMI|6.26|per second|C0565930|[qnco]|["/s"-tx-13-"s"-prep-0,"/s"-tx-10-"("-noun-0]|TX|3392/1;2450/1|
00000000|MMI|6.26|Instructions:Text:Point in time:^Patient:Narrative|C3263700|[clna]|["Instructions"-tx-10-"Instructions"-noun-0,"Instructions"-tx-3-"Instructions"-noun-0]|TX|2214/12;1014/12|
00000000|MMI|6.25|1 Day|C1442449|[tmco]|["Day 1"-tx-47-"1 day"-noun-0,"1 Day"-tx-14-"1 day"-noun-0]|TX|6504/1,6509/3;3633/5|
00000000|MMI|6.25|Following|C0332282|[tmco]|["Following"-tx-44-"following"-adj-0,"Following"-tx-38-"following"-verb-0]|TX|6087/9;5556/9|
00000000|MMI|6.25|Status post|C0231290|[tmco]|["Following"-tx-44-"following"-adj-0,"Following"-tx-38-"following"-verb-0]|TX|6087/9;5556/9|
00000000|MMI|6.24|second (number)|C0205436|[qnco]|["2nd"-tx-32-"2nd"-numeric_ordinal-0,"2nd"-tx-21-"2nd"-numeric_ordinal-0]|TX|5204/3;4409/3|
00000000|MMI|6.23|Renal Failure Adverse Event|C1963154|[patf]|["Renal failure"-tx-32-"renal failure"-noun-0,"Renal failure"-tx-24-"renal failure"-noun-0]|TX|5211/13;4643/13|
00000000|MMI|6.21|Increase|C0442805|[ftcn]|["Increased"-tx-44-"increased"-verb-0]|TX|[6138/9],[6188/9]|
00000000|MMI|6.21|Increased|C0205217|[qnco]|["Increased"-tx-44-"increased"-verb-0]|TX|[6138/9],[6188/9]|
00000000|MMI|6.20|Empty (qualifier)|C1880497|[qlco]|["Empty"-tx-10-"empty"-adj-0,"Empty"-tx-2-"empty"-adj-0]|TX|1887/5;931/5|
00000000|MMI|6.20|Entire stomach|C1278920|[bpoc]|["Stomach"-tx-10-"stomach"-noun-0,"Stomach"-tx-2-"stomach"-noun-0]|TX|1893/7;937/7|
00000000|MMI|6.20|Gastric Tissue|C1517454|[tisu]|["STOMACH"-tx-10-"stomach"-noun-0,"STOMACH"-tx-2-"stomach"-noun-0]|TX|1893/7;937/7|
00000000|MMI|6.20|Stomach structure|C3714551|[bpoc]|["Stomach"-tx-10-"stomach"-noun-0,"Stomach"-tx-2-"stomach"-noun-0]|TX|1893/7;937/7|
00000000|MMI|6.19|carmustine/methotrexate/procarbazine protocol|C0279266|[topp]|["BMP"-tx-27-"BMP"-noun-0,"BMP"-tx-26-"BMP"-noun-0]|TX|4814/3;4774/3|
00000000|MMI|6.19|Additional|C1524062|[ftcn]|["Added"-tx-6-"added"-verb-0,"Added"-tx-3-"added"-verb-0]|TX|1474/5;1152/5|
00000000|MMI|6.18|Weekly|C0332174|[tmco]|["/week"-tx-14-"week"-noun-0,"/week"-tx-13-"week"-noun-0]|TX|3622/4;3435/4|
00000000|MMI|6.18|week|C0439230|[tmco]|["WEEK"-tx-14-"week"-noun-0,"WEEK"-tx-13-"week"-noun-0]|TX|3622/4;3435/4|
00000000|MMI|6.17|Phoslo|C0722621|[orch,phsu]|["PhosLo"-tx-44-"phoslo"-noun-0,"PhosLo"-tx-2-"PHOSLO"-noun-0]|TX|6247/6;426/6|
00000000|MMI|6.17|Subject Continuance|C2826258|[evnt]|["CONT"-tx-43-"cont"-noun-0,"CONT"-tx-22-"cont"-noun-0]|TX|5930/4;4453/4|
00000000|MMI|6.16|day|C0439228|[tmco]|["DAY"-tx-44-"day"-noun-0,"DAY"-tx-2-"DAY"-noun-0]|TX|6342/3;488/3|
00000000|MMI|6.16|per day|C0439505|[tmco]|["/day"-tx-44-"day"-noun-0,"/day"-tx-2-"DAY"-noun-0]|TX|6342/3;488/3|
00000000|MMI|6.15|((5,6-dichloro-2,3,9,9a-tetrahydro-3-oxo-9a-propyl-1H-fluoren-7-yl)oxy)acetic acid|C0378071|[orch,phsu]|["b-3"-tx-9-"B-3"-adj-0,"b-3"-tx-5-"B-3"-adj-0]|TX|1566/3;1291/3|
00000000|MMI|6.13|Symptoms|C1457887|[sosy]|["Symptom"-tx-14-"symptom"-noun-0,"SYMPTOMS"-tx-2-"Symptoms"-noun-0]|TX|3648/7;652/8|
00000000|MMI|6.12|Home environment|C0442519|[cnce]|["house"-tx-40-"house"-adj-0,"HOME"-tx-10-"home"-noun-0]|TX|5689/5;2237/4|
00000000|MMI|6.12|Started|C1272689|[qlco]|["Started"-tx-44-"started"-adj-0,"Started"-tx-42-"Started"-verb-0]|TX|6222/7;5876/7|
00000000|MMI|6.11|Dosage|C0178602|[qnco]|["DOSE"-tx-40-"dose"-noun-0,"DOSE"-tx-10-"dose"-noun-0]|TX|5674/4;2242/4|
00000000|MMI|6.11|Unit dose|C0869039|[qnco]|["Dose"-tx-40-"dose"-noun-0,"Dose"-tx-10-"dose"-noun-0]|TX|5674/4;2242/4|
00000000|MMI|6.10|Base|C0178499|[chvf]|["Base"-tx-20-"base"-noun-0,"bases"-tx-20-"bases"-noun-0]|TX|4186/4;4158/5|
00000000|MMI|6.10|Curriculum Vitae|C1880201|[inpr]|["Resume"-tx-13-"RESUME"-noun-0,"Resume"-tx-10-"Resume"-noun-0]|TX|3276/6;2405/6|
00000000|MMI|6.10|Resume - Remote control command|C1550028|[idcn]|["Resume"-tx-13-"RESUME"-noun-0,"Resume"-tx-10-"Resume"-noun-0]|TX|3276/6;2405/6|
00000000|MMI|6.10|resume - DataOperation|C3242342|[ftcn]|["resume"-tx-13-"RESUME"-noun-0,"resume"-tx-10-"Resume"-noun-0]|TX|3276/6;2405/6|
00000000|MMI|6.09|mg/mg|C1319635|[qnco]|["mg/mg"-tx-2-"MG MG"-noun-0]|TX|[457/2,485/2],[768/2,821/2]|
00000000|MMI|6.07|R prime|C2603358|[clna]|["R'"-tx-20-"R"-noun-0,"R'"-tx-13-"R"-noun-0]|TX|4178/1;3231/1|
00000000|MMI|6.07|Right|C0205090|[spco]|["R-"-tx-20-"R"-noun-0,"R-"-tx-13-"R"-noun-0]|TX|4178/1;3231/1|
00000000|MMI|6.07|Full|C0443225|[qlco]|["Full"-tx-44-"FULL"-adj-0,"Full"-tx-2-"Full"-adj-0]|TX|6017/4;287/4|
00000000|MMI|6.07|Stent Device Component|C1705817|[medd]|["Stent"-tx-21-"stent"-noun-0,"Stent"-tx-13-"stent"-noun-0]|TX|4387/5;3396/5|
00000000|MMI|6.05|Serious|C0205404|[qlco]|["Serious"-tx-8-"SERIOUS"-adj-0,"Serious"-tx-4-"SERIOUS"-adj-0]|TX|1531/7;1256/7|
00000000|MMI|6.03|Administration procedure|C1533734|[topp]|["Treatment"-tx-13-"Treatment"-noun-0,"Treatment"-tx-2-"Treatment"-noun-0]|TX|2821/9;715/9|
00000000|MMI|6.03|Biomaterial Treatment|C1705169|[cnce]|["Treatment"-tx-13-"Treatment"-noun-0,"Treatment"-tx-2-"Treatment"-noun-0]|TX|2821/9;715/9|
00000000|MMI|6.03|Treating|C1522326|[ftcn]|["Treatment"-tx-13-"Treatment"-noun-0,"Treatment"-tx-2-"Treatment"-noun-0]|TX|2821/9;715/9|
00000000|MMI|6.03|Treatment Epoch|C3538994|[resa]|["TREATMENT"-tx-13-"Treatment"-noun-0,"TREATMENT"-tx-2-"Treatment"-noun-0]|TX|2821/9;715/9|
00000000|MMI|6.03|treatment - ActInformationManagementReason|C3887704|[hlca]|["treatment"-tx-13-"Treatment"-noun-0,"treatment"-tx-2-"Treatment"-noun-0]|TX|2821/9;715/9|
00000000|MMI|6.03|30%|C3842588|[fndg]|["30%"-tx-12-"30"-integer-0,"30%"-tx-11-"30"-integer-0]|TX|2534/2;2487/2|
00000000|MMI|6.01|0%|C3842591|[fndg]|["0%"-tx-2-"0"-real_number-0]|TX|[409/1],[481/1]|
00000000|MMI|6.01|TMPO wt Allele|C3541334|[gngm]|["TP"-tx-3-"TP"-noun-0,"TP"-tx-2-"TP"-noun-0]|TX|1007/2;492/2|
00000000|MMI|6.01|Today|C0310367|[antb,orch]|["Today"-tx-10-"Today"-noun-0]|TX|[1809/5],[2202/5]|
00000000|MMI|6.01|Today (temporal qualifier)|C0750526|[tmco]|["Today"-tx-10-"Today"-noun-0]|TX|[1809/5],[2202/5]|
00000000|MMI|5.99|Now (temporal qualifier)|C1948052|[tmco]|["Now"-tx-44-"now"-adv-0,"Now"-tx-37-"now"-adv-0]|TX|6170/3;5489/3|
00000000|MMI|5.99|55|C0450382|[inpr]|["55"-tx-18-"55"-percentage-0,"55"-tx-2-"55"-integer-0]|TX|3922/2;859/2|
00000000|MMI|5.98|Primary|C0205225|[qlco]|["Primary"-tx-23-"primary"-adj-0,"Principal"-tx-13-"PRINCIPAL"-adj-0]|TX|4502/7;2657/9|
00000000|MMI|5.98|CFH gene|C1538440|[gngm]|["HF"-tx-24-"HF"-noun-0,"HF"-tx-21-"HF"-noun-0]|TX|4567/2;4449/2|
00000000|MMI|5.98|CFH wt Allele|C3273279|[gngm]|["HF"-tx-24-"HF"-noun-0,"HF"-tx-21-"HF"-noun-0]|TX|4567/2;4449/2|
00000000|MMI|5.98|Unit|C0439148|[qnco]|["UNITS"-tx-10-"UNITS"-noun-0,"UNITS"-tx-2-"UNITS"-noun-0]|TX|2181/5;535/5|
00000000|MMI|5.98|Unit - NCI Thesaurus Property|C3853603|[ftcn]|["Units"-tx-10-"UNITS"-noun-0,"Units"-tx-2-"UNITS"-noun-0]|TX|2181/5;535/5|
00000000|MMI|5.98|Unit of Measure|C1519795|[qnco]|["Units"-tx-10-"UNITS"-noun-0,"Units"-tx-2-"UNITS"-noun-0]|TX|2181/5;535/5|
00000000|MMI|5.96|Posterior interventricular branch of right coronary artery|C0226047|[bpoc]|["PDA"-tx-17-"PDA"-noun-0,"PDA"-tx-13-"PDA"-noun-0]|TX|3875/3;3405/3|
00000000|MMI|5.92|Transplanted tissue|C0332835|[tisu]|["GRAFT"-tx-13-"graft"-noun-0]|TX|3256/5|A01.941
00000000|MMI|5.86|Allergic Reaction|C1527304|[patf]|["Allergy"-tx-13-"ALLERGY"-noun-0]|TX|2601/7|C20.543
00000000|MMI|5.86|Hypersensitivity|C0020517|[patf]|["ALLERGY"-tx-13-"ALLERGY"-noun-0]|TX|2601/7|C20.543
00000000|MMI|5.73|Limb structure|C0015385|[bpoc]|["Extremity"-tx-13-"extremity"-noun-0]|TX|3485/9|A01.378
00000000|MMI|5.70|Alkalies|C0002055|[inch]|["base"-tx-20-"base"-noun-0]|TX|4186/4|D01.045
00000000|MMI|5.69|Inhaler|C0021461|[medd]|["INHALER"-tx-10-"INHALER"-noun-0]|TX|2295/7|E07.605
00000000|MMI|4.49|*Activity (kind of quantity)|C1561536|[idcn]|["*Activity"-tx-16-"activity"-noun-0]|TX|3768/8|
00000000|MMI|4.49|+5|C0728893|[qnco]|["+5"-tx-40-"5"-integer-0]|TX|5603/1|
00000000|MMI|4.49|3+ Answer to Question|C3838680|[fndg]|["3+"-tx-31-"3"-integer-0]|TX|5096/1|
00000000|MMI|4.49|3+ Score|C2827736|[qnco]|["3+"-tx-31-"3"-integer-0]|TX|5096/1|
00000000|MMI|4.49|3+ Score, WHO|C2981702|[clas]|["3+"-tx-31-"3"-integer-0]|TX|5096/1|
00000000|MMI|4.49|<3 (qualifier value)|C0439086|[qnco]|["<3"-tx-31-"3"-integer-0]|TX|5096/1|
00000000|MMI|4.49|>5|C0439084|[qnco]|[">5"-tx-40-"5"-integer-0]|TX|5603/1|
00000000|MMI|4.49|Ability to Sit question|C4050224|[inpr]|["Sitting"-tx-20-"Sitting"-noun-0]|TX|4016/7|
00000000|MMI|4.49|Accept - Source type|C1548601|[idcn]|["Accept"-tx-36-"accept"-verb-0]|TX|5425/6|
00000000|MMI|4.49|Accepted|C1272684|[qlco]|["accept"-tx-36-"accept"-verb-0]|TX|5425/6|
00000000|MMI|4.49|ActInformationPrivacyReason <operations>|C3244305|[ftcn]|["operations"-tx-13-"OPERATIONS"-noun-0]|TX|3160/10|
00000000|MMI|4.49|Active|C0205177|[ftcn]|["Activity"-tx-16-"activity"-noun-0]|TX|3768/8|
00000000|MMI|4.49|Activities|C0441655|[acty]|["ACTIVITY"-tx-16-"activity"-noun-0]|TX|3768/8|
00000000|MMI|4.49|Activity (animal life circumstance)|C3668946|[fndg]|["Activity"-tx-16-"activity"-noun-0]|TX|3768/8|
00000000|MMI|4.49|Additional comments|C1830770|[fndg]|["Additional comments"-tx-44-"ADDITIONAL COMMENTS"-noun-0]|TX|6032/19|
00000000|MMI|4.49|Affecting|C0392760|[ftcn]|["Affecting"-tx-13-"affecting"-verb-0]|TX|2811/9|
00000000|MMI|4.49|Allergy Clinical Status - Suspect|C1571873|[idcn]|["Suspect"-tx-29-"suspect"-verb-0]|TX|4899/7|
00000000|MMI|4.49|Approximate|C0332232|[qlco]|["Approximate"-tx-10-"approximate"-adj-0]|TX|2056/11|
00000000|MMI|4.49|Apyrexial|C0277797|[fndg]|["Afebrile"-tx-19-"Afebrile"-adj-0]|TX|3984/8|
00000000|MMI|4.49|Basal Diet|C2983588|[food]|["DIET"-tx-10-"DIET"-noun-0]|TX|2353/4|
00000000|MMI|4.49|Basilar Rales|C0240859|[fndg]|["Rales"-tx-20-"Rales"-noun-0]|TX|4126/5|
00000000|MMI|4.49|Before - dosing instruction fragment|C1705850|[inpr]|["Before"-tx-49-"before"-adv-0]|TX|6628/6|
00000000|MMI|4.49|Biomedical tape|C0183828|[medd]|["TAPE"-tx-13-"Tape"-noun-0]|TX|2610/4|
00000000|MMI|4.49|Body Fluids and Substances|C1521806|[tisu]|["Fluids"-tx-29-"fluids"-noun-0]|TX|4912/6|
00000000|MMI|4.49|Both kidneys|C0227665|[bpoc]|["kidney"-tx-12-"Kidney"-noun-0]|TX|2517/6|
00000000|MMI|4.49|CR2 wt Allele|C3539604|[gngm]|["CR"-tx-33-"Cr"-noun-0]|TX|5259/2|
00000000|MMI|4.49|Calcitriol Drug Class|C3714610|[phsu,vita]|["CALCITRIOL"-tx-2-"CALCITRIOL"-noun-0]|TX|396/10|
00000000|MMI|4.49|Cardiovascular System Findings Domain|C3538987|[idcn]|["CV"-tx-20-"CV"-noun-0]|TX|4082/2|
00000000|MMI|4.49|Certain (qualifier value)|C0205423|[qlco]|["Sure"-tx-49-"sure"-adj-0]|TX|6598/4|
00000000|MMI|4.49|Chest pain:Finding:Point in time:^Patient:Ordinal|C2926613|[clna]|["Chest pain"-tx-45-"chest pain"-noun-0]|TX|6398/10|
00000000|MMI|4.49|Complication|C0009566|[patf]|["Complications"-tx-13-"Complications"-noun-0]|TX|2795/13|
00000000|MMI|4.49|Continuous|C0549178|[idcn]|["Continued"-tx-28-"continued"-verb-0]|TX|4866/9|
00000000|MMI|4.49|Creatinine measurement|C0201975|[lbpr]|["Cr"-tx-33-"Cr"-noun-0]|TX|5259/2|
00000000|MMI|4.49|Demand (clinical)|C0441516|[topp]|["Demand"-tx-21-"demand"-verb-0]|TX|4416/6|
00000000|MMI|4.49|Diet (animal life circumstance)|C3668949|[food]|["Diet"-tx-10-"DIET"-noun-0]|TX|2353/4|
00000000|MMI|4.49|Dietary indiscretion|C1321006|[fndg]|["Dietary indiscretion"-tx-24-"dietary indiscretion"-noun-0]|TX|4608/20|
00000000|MMI|4.49|Diffuse|C0205219|[qlco]|["DIFFUSE"-tx-20-"diffuse"-verb-0]|TX|4132/7|
00000000|MMI|4.49|Discharge date|C2361123|[tmco]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|0/14|
00000000|MMI|4.49|Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2361122|[clna]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|0/14|
00000000|MMI|4.49|Does skip|C0560435|[fndg]|["skip"-tx-47-"skip"-verb-0]|TX|6525/4|
00000000|MMI|4.49|Economic demand|C0699784|[idcn]|["demand"-tx-21-"demand"-verb-0]|TX|4416/6|
00000000|MMI|4.49|Entire kidney|C1278978|[bpoc]|["Kidney"-tx-12-"Kidney"-noun-0]|TX|2517/6|
00000000|MMI|4.49|Evaluation and management note:Finding:Point in time:{Setting}:Document:{Provider}|C1316572|[clna]|["Note"-tx-44-"note"-verb-0]|TX|6060/4|
00000000|MMI|4.49|FDA Establishment Activity Terminology|C4049939|[inpr]|["ACTIVITY"-tx-16-"activity"-noun-0]|TX|3768/8|
00000000|MMI|4.49|Fatigue Subordinate Domain|C4050243|[inpr]|["Fatigue"-tx-2-"Fatigue"-noun-0]|TX|662/7|
00000000|MMI|4.49|Fluticasone propionate|C0117996|[orch,phsu]|["FLUTICASONE PROPIONATE"-tx-10-"FLUTICASONE PROPIONATE"-noun-0]|TX|1949/22|
00000000|MMI|4.49|GEN1 gene|C2239486|[gngm]|["Gen"-tx-20-"Gen"-noun-0]|TX|4011/3|
00000000|MMI|4.49|HL7PublishingSubSection <operations>|C3244306|[inpr]|["operations"-tx-13-"OPERATIONS"-noun-0]|TX|3160/10|
00000000|MMI|4.49|Half|C2825407|[qnco]|["Half"-tx-10-"half"-noun-0]|TX|2228/4|
00000000|MMI|4.49|Hypertension Adverse Event|C1963138|[fndg]|["Hypertension"-tx-13-"hypertension"-noun-0]|TX|2873/12|
00000000|MMI|4.49|Identifier|C0600091|[inpr]|["ID"-tx-13-"ID"-noun-0]|TX|3371/2|
00000000|MMI|4.49|Immune diffusion|C1441613|[lbpr]|["ID"-tx-13-"ID"-noun-0]|TX|3371/2|
00000000|MMI|4.49|Interventional procedure|C0184661|[topp]|["PROCEDURES"-tx-13-"PROCEDURES"-noun-0]|TX|3175/10|
00000000|MMI|4.49|Involvement with|C1314939|[ftcn]|["Affecting"-tx-13-"affecting"-verb-0]|TX|2811/9|
00000000|MMI|4.49|Lamotrigine measurement|C0524166|[lbpr]|["lamotrigine"-tx-10-"LAMOTRIGINE"-noun-0]|TX|2001/11|
00000000|MMI|4.49|Last|C1517741|[qlco]|["Last"-tx-2-"Last"-verb-0]|TX|585/4|
00000000|MMI|4.49|Left|C0205091|[spco]|["LEFT"-tx-20-"left"-verb-0]|TX|4263/4|
00000000|MMI|4.49|Left sided|C0443246|[spco]|["Left"-tx-20-"left"-verb-0]|TX|4263/4|
00000000|MMI|4.49|Liquid substance|C0302908|[sbst]|["fluids"-tx-29-"fluids"-noun-0]|TX|4912/6|
00000000|MMI|4.49|MANEA gene|C1427293|[gngm]|["ENDO"-tx-40-"ENDO"-adj-0]|TX|5651/4|
00000000|MMI|4.49|Measurement|C0242485|[ftcn]|["Measure"-tx-10-"measure"-verb-0]|TX|2374/7|
00000000|MMI|4.49|Medications:-:Point in time:^Patient:-|C2598133|[clna]|["Medications"-tx-2-"MEDICATIONS"-noun-0]|TX|337/11|
00000000|MMI|4.49|Medications:Presence or Identity:Duration of the study:^Patient:Nominal|C0802604|[clna]|["Medications"-tx-2-"MEDICATIONS"-noun-0]|TX|337/11|
00000000|MMI|4.49|New|C0205314|[qlco]|["NEW"-tx-20-"new"-adj-0]|TX|4302/3|
00000000|MMI|4.49|Note (document)|C1317574|[inpr]|["Note"-tx-44-"note"-verb-0]|TX|6060/4|
00000000|MMI|4.49|On admission|C0457453|[tmco]|["On admission"-tx-22-"on admission"-adj-0]|TX|4482/12|
00000000|MMI|4.49|Open|C0175566|[spco]|["Open"-tx-44-"open"-verb-0]|TX|6329/4|
00000000|MMI|4.49|Orthopnea|C0085619|[sosy]|["Orthopnoea"-tx-13-"orthopnea"-noun-0]|TX|3467/9|
00000000|MMI|4.49|PANIC DISORDER 1|C1868649|[dsyn]|["PANIC DISORDER"-tx-13-"panic disorder"-noun-0]|TX|2924/14|
00000000|MMI|4.49|PLP1 wt Allele|C2698697|[gngm]|["PMD"-tx-11-"PMD"-noun-0]|TX|2470/3|
00000000|MMI|4.49|Percent Activity|C0439167|[qnco]|["% Activity"-tx-16-"activity"-noun-0]|TX|3768/8|
00000000|MMI|4.49|Pharmaceutical Preparations|C0013227|[phsu]|["Medications"-tx-2-"MEDICATIONS"-noun-0]|TX|337/11|D26
00000000|MMI|4.49|Physical Activity Measurement|C4049938|[lbpr]|["ACTIVITY"-tx-16-"activity"-noun-0]|TX|3768/8|
00000000|MMI|4.49|Physician:Identifier:Point in time:^Patient:Nominal|C0804815|[clna]|["Physician"-tx-38-"physician"-noun-0]|TX|5566/9|
00000000|MMI|4.49|Procedure (set of actions)|C2700391|[acty]|["Procedures"-tx-13-"PROCEDURES"-noun-0]|TX|3175/10|
00000000|MMI|4.49|Progressive Metabolic Disease|C4050223|[fndg]|["PMD"-tx-11-"PMD"-noun-0]|TX|2470/3|
00000000|MMI|4.49|Psychiatric problem|C1306597|[mobd]|["psych"-tx-43-"PSYCH"-noun-0]|TX|5910/5|
00000000|MMI|4.49|Pulmonary ventilator management|C1315068|[hlca]|["PULM"-tx-20-"Pulm"-adj-0]|TX|4120/4|
00000000|MMI|4.49|Pump Device Component|C1706421|[mnob]|["Pump"-tx-24-"PUMP"-noun-0]|TX|4542/4|
00000000|MMI|4.49|Renal Tissue|C1514845|[tisu]|["KIDNEY"-tx-12-"Kidney"-noun-0]|TX|2517/6|
00000000|MMI|4.49|Requirement|C1514873|[ftcn]|["Required"-tx-10-"Required"-verb-0]|TX|2045/8|
00000000|MMI|4.49|Rhythm|C0871269|[fndg]|["Rhythm"-tx-31-"RHYTHM"-noun-0]|TX|5100/6|
00000000|MMI|4.49|Rhythm Not Otherwise Specified ECG Assessment|C3828331|[inpr]|["Rhythm Not Otherwise Specified"-tx-31-"RHYTHM"-noun-0]|TX|5100/6|
00000000|MMI|4.49|Send (transmission)|C1519246|[ftcn]|["Send"-tx-41-"send"-verb-0]|TX|5846/4|
00000000|MMI|4.49|Shaving - surgical procedure|C0522772|[topp]|["Shaving"-tx-15-"shaving"-noun-0]|TX|3735/7|
00000000|MMI|4.49|Shin|C0230444|[blor]|["Shin"-tx-3-"shin"-verb-0]|TX|1037/4|
00000000|MMI|4.49|Sitting Function|C2584297|[phsf]|["Sitting"-tx-20-"Sitting"-noun-0]|TX|4016/7|
00000000|MMI|4.49|Sitting position|C0277814|[fndg]|["SITTING"-tx-20-"Sitting"-noun-0]|TX|4016/7|
00000000|MMI|4.49|Special Diet Therapy|C1519433|[topp]|["DIET"-tx-10-"DIET"-noun-0]|TX|2353/4|
00000000|MMI|4.49|Suspected qualifier|C0750491|[idcn]|["suspect"-tx-29-"suspect"-verb-0]|TX|4899/7|
00000000|MMI|4.49|Table Cell Horizontal Align - left|C1552822|[ftcn]|["left"-tx-20-"left"-verb-0]|TX|4263/4|
00000000|MMI|4.49|Take|C1515187|[hlca]|["Take"-tx-2-"Take"-verb-0]|TX|896/4|
00000000|MMI|4.49|Tape Device Component|C1704921|[mnob]|["Tape"-tx-13-"Tape"-noun-0]|TX|2610/4|
00000000|MMI|4.49|Therapeutic|C0302350|[ftcn]|["Therapeutic"-tx-3-"THERAPEUTIC"-adj-0]|TX|1072/11|E02
00000000|MMI|4.49|Unable|C1299582|[fndg]|["Unable"-tx-41-"unable"-adj-0]|TX|5836/6|
00000000|MMI|4.49|Weight Gain Adverse Event|C2911647|[fndg]|["Weight gain"-tx-28-"weight gain"-noun-0]|TX|4884/11|
00000000|MMI|4.49|Weights - exercise activity|C3812400|[fndg]|["Weights"-tx-25-"weights"-noun-0]|TX|4737/7|
00000000|MMI|4.49|doubt|C0870444|[menp]|["doubt"-tx-23-"Doubt"-verb-0]|TX|4496/5|
00000000|MMI|4.49|peripheral blood|C0229664|[bdsu]|["BLOOD"-tx-49-"blood"-noun-0]|TX|6616/5|
00000000|MMI|4.49|pump (device)|C0182537|[medd]|["Pump"-tx-24-"PUMP"-noun-0]|TX|4542/4|
00000000|MMI|4.49|rhythmic process (biological)|C1523018|[phsf]|["rhythm"-tx-31-"RHYTHM"-noun-0]|TX|5100/6|
00000000|MMI|4.49|therapeutic multivitamins|C0724703|[phsu,vita]|["therapeutic multivitamins"-tx-3-"THERAPEUTIC MULTIVITAMINS"-noun-0]|TX|1086/25|
00000000|MMI|4.49|treatments and procedures|C0237403|[topp]|["treatments procedures"-tx-13-"TREATMENTS/PROCEDURES"-noun-0]|TX|3198/21|
00000000|MMI|3.44|Long|C0205166|[qlco]|["Long"-tx-30-"longer"-adj-0]|TX|4988/6|
00000000|MMI|3.44|Long Variable|C1706317|[qlco]|["Long"-tx-30-"longer"-adj-0]|TX|4988/6|
00000000|MMI|3.44|Restart|C1514902|[qlco]|["Restart"-tx-27-"Restarted"-verb-0]|TX|4796/9|
00000000|MMI|3.30|Swelling of lower leg|C0745977|[sosy]|["lower leg swelling"-tx-13-"lower leg swelling"-noun-0]|TX|3479/5,3495/12|
00000000|MMI|3.30|Swollen legs|C0581394|[sosy]|["lower extremity swelling"-tx-13-"lower extremity swelling"-noun-0]|TX|3479/15,3499/8|
00000000|MMI|3.28|exacerbation acute|C0743630|[fndg]|["acute exacerbation"-tx-24-"acute exacerbation"-noun-0]|TX|4575/5,4588/12|
00000000|MMI|3.25|Second heart sound split|C0425619|[fndg]|["Split S2"-tx-20-"split s2"-noun-1]|TX|4092/8|
00000000|MMI|3.21|Ulcer of shin|C0586391|[dsyn]|["shin ulcer"-tx-20-"shin ulcer"-noun-0]|TX|4277/4,4294/5|
00000000|MMI|3.19|ALYREF gene|C1425988|[gngm]|["REF"-tx-4-"ref"-noun-0]|TX|1227/3|
00000000|MMI|3.19|Attending (action)|C1999232|[ftcn]|["attending"-tx-1-"Attending"-noun-0]|TX|227/9|
00000000|MMI|3.19|Attending (provider role)|C1547429|[prog]|["Attending"-tx-1-"Attending"-noun-0]|TX|227/9|
00000000|MMI|3.19|Axial R|C3538806|[spco]|["Ra"-tx-19-"RA"-noun-0]|TX|4007/2|
00000000|MMI|3.19|Band form|C0439645|[spco]|["Band"-tx-16-"band"-adj-0]|TX|3779/4|
00000000|MMI|3.19|Bands|C0175723|[medd]|["Band"-tx-16-"band"-adj-0]|TX|3779/4|
00000000|MMI|3.19|Chromosome band|C1521913|[celc]|["band"-tx-16-"band"-adj-0]|TX|3779/4|
00000000|MMI|3.19|Graft material|C0181074|[bodm]|["{Graft}"-tx-13-"graft"-noun-0]|TX|3256/5|
00000000|MMI|3.19|Grafting procedure|C1961139|[topp]|["Graft, NOS"-tx-13-"graft"-noun-0]|TX|3256/5|
00000000|MMI|3.19|March|C3829202|[qlco]|["March"-tx-12-"March"-noun-0]|TX|2526/5|
00000000|MMI|3.19|Methylcytosine Dioxygenase TET1|C2987138|[aapp,enzy]|["LCX"-tx-17-"LCx"-noun-0]|TX|3891/3|
00000000|MMI|3.19|Mononit|C0968321|[orch,phsu]|["Mononit"-tx-10-"MONONIT"-noun-0]|TX|1770/7|
00000000|MMI|3.19|Right arm|C4048756|[bpoc]|["RA"-tx-19-"RA"-noun-0]|TX|4007/2|
00000000|MMI|3.19|Status|C0449438|[qlco]|["Status"-tx-2-"STATUS"-noun-0]|TX|279/6|
00000000|MMI|3.19|Symptoms aspect|C0683368|[ftcn]|["symptoms"-tx-2-"Symptoms"-noun-0]|TX|652/8|
00000000|MMI|3.19|TET1 gene|C1428863|[gngm]|["LCX"-tx-17-"LCx"-noun-0]|TX|3891/3|
00000000|MMI|3.19|TET1 wt Allele|C2987137|[gngm]|["LCX"-tx-17-"LCx"-noun-0]|TX|3891/3|
00000000|MMI|3.16|Subclinical hypothyroidism|C0271790|[dsyn]|["subclinical hypothyroid"-tx-40-"subclinical hypothyroid"-noun-0]|TX|5716/23|
00000000|MMI|3.16|Monday through Friday|C1306057|[tmco]|["M-F"-tx-44-"m f"-noun-0]|TX|6240/1,6244/1|
00000000|MMI|3.16|Principal Diagnosis:-:Point in time:^Patient:-|C2598194|[clna]|["Principal Diagnosis"-tx-13-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|2657/9,2677/9|
00000000|MMI|3.16|Principal diagnosis|C0332137|[qlco]|["Principal Diagnosis"-tx-13-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|2657/9,2677/9|
00000000|MMI|3.15|Entered|C1521975|[qlco]|["Entered"-tx-50-"ENTERED"-verb-0]|TX|6705/7|
00000000|MMI|3.15|Radiating to|C0332301|[ftcn]|["Radiating to"-tx-16-"radiating to"-verb-0]|TX|3791/12|
00000000|MMI|3.15|80%|C3842583|[fndg]|["80%"-tx-19-"80"-integer-0]|TX|3967/2|
00000000|MMI|3.15|Block Specimens|C1533157|[sbst]|["Blocks"-tx-15-"blocks"-noun-0]|TX|3711/6|
00000000|MMI|3.15|Block Unit of Distance|C3811660|[qnco]|["BLOCKS"-tx-15-"blocks"-noun-0]|TX|3711/6|
00000000|MMI|3.15|Blocking|C0332206|[ftcn]|["blocks"-tx-15-"blocks"-noun-0]|TX|3711/6|
00000000|MMI|3.15|Diabetes|C0011847|[dsyn]|["Diabetes"-tx-13-"diabetes"-noun-0]|TX|2836/8|
00000000|MMI|3.15|Disposition|C0743223|[idcn]|["Disposition"-tx-2-"DISPOSITION"-noun-0]|TX|297/11|
00000000|MMI|3.15|Disposition Domain|C1705555|[inpr]|["Disposition"-tx-2-"DISPOSITION"-noun-0]|TX|297/11|
00000000|MMI|3.15|Early infantile epileptic encephalopathy with suppression bursts|C0393706|[dsyn]|["OS"-tx-25-"Os"-noun-0]|TX|4732/2|
00000000|MMI|3.15|HEENT|C1512338|[blor]|["HEENT"-tx-20-"Heent"-noun-0]|TX|4044/5|
00000000|MMI|3.15|HP gene|C1415692|[gngm]|["Bp"-tx-19-"BP"-noun-0]|TX|3972/2|
00000000|MMI|3.15|HP wt Allele|C1708288|[gngm]|["BP"-tx-19-"BP"-noun-0]|TX|3972/2|
00000000|MMI|3.15|Left eye structure|C0229090|[bpoc]|["OS"-tx-25-"Os"-noun-0]|TX|4732/2|
00000000|MMI|3.15|NT5E wt Allele|C3889152|[gngm]|["NT"-tx-20-"NT"-noun-0]|TX|4211/2|
00000000|MMI|3.15|No treatment required for|C0332126|[qlco]|["NT"-tx-20-"NT"-noun-0]|TX|4211/2|
00000000|MMI|3.15|Obstruction|C0028778|[patf]|["blocks"-tx-15-"blocks"-noun-0]|TX|3711/6|
00000000|MMI|3.15|Oral region|C0230028|[blor]|["Os"-tx-25-"Os"-noun-0]|TX|4732/2|
00000000|MMI|3.15|Pounds|C0439219|[qnco]|["lbs"-tx-47-"lbs"-noun-0]|TX|6519/3|
00000000|MMI|3.15|Probable diagnosis|C0332148|[qlco]|["Likely"-tx-21-"likely"-adj-0]|TX|4395/6|
00000000|MMI|3.15|Probably|C0750492|[idcn]|["Likely"-tx-21-"likely"-adj-0]|TX|4395/6|
00000000|MMI|3.15|Protonix|C0876139|[orch,phsu]|["Protonix"-tx-10-"PROTONIX"-noun-0]|TX|2247/8|
00000000|MMI|3.15|Skeletal bone|C0262950|[bpoc]|["Os"-tx-25-"Os"-noun-0]|TX|4732/2|
00000000|MMI|3.15|Supernumerary mandibular left central primary incisor|C1561953|[bpoc]|["Os"-tx-25-"Os"-noun-0]|TX|4732/2|
00000000|MMI|3.15|Tyrosine Nitration|C4050156|[moft]|["NT"-tx-20-"NT"-noun-0]|TX|4211/2|
00000000|MMI|3.15|discharge diagnosis|C1555319|[fndg]|["Discharge diagnosis"-tx-13-"DISCHARGE DIAGNOSIS"-noun-0]|TX|2667/19|
00000000|MMI|3.15|liquid-based cytology (procedure)|C3161851|[lbpr]|["LBS"-tx-47-"lbs"-noun-0]|TX|6519/3|
00000000|MMI|3.13|Short menstrual periods|C0425946|[fndg]|["short Time Period"-tx-30-"short period time"-noun-1]|TX|5074/12,5090/4|
00000000|MMI|3.13|Allergic disposition|C3539909|[dsyn]|["Allergy"-tx-13-"ALLERGY"-noun-0]|TX|2601/7|
00000000|MMI|3.13|Allergy - Physicians|C1554743|[prog]|["Allergy"-tx-13-"ALLERGY"-noun-0]|TX|2601/7|
00000000|MMI|3.13|Response to antigens|C1314973|[phsf]|["ALLERGY"-tx-13-"ALLERGY"-noun-0]|TX|2601/7|
00000000|MMI|3.13|Unit dose - Base|C1626935|[qnco]|["Bases"-tx-20-"bases"-noun-0]|TX|4158/5|
00000000|MMI|3.12|Lamictal|C0678180|[orch,phsu]|["Lamiktal"-tx-10-"LAMICTAL"-noun-0]|TX|1990/8|
00000000|MMI|3.12|Trileptal|C0876196|[orch,phsu]|["Trileptal"-tx-10-"TRILEPTAL"-noun-0]|TX|2108/9|
00000000|MMI|3.12|Day 2|C3842676|[fndg]|["Day 2"-tx-38-"2 days"-noun-0]|TX|5532/6|
00000000|MMI|3.12|Account number:Identifier:Point in time:^Patient:Nominal|C2741673|[clna]|["Account #"-tx-29-"accounted"-verb-0]|TX|4946/9|
00000000|MMI|3.12|Financial Account|C2981730|[inpr]|["Account"-tx-29-"accounted"-verb-0]|TX|4946/9|
00000000|MMI|3.12|event cycle|C1511572|[tmco]|["Cycle"-tx-2-"Cycle"-noun-0]|TX|725/5|
00000000|MMI|3.11|ActInformationPrivacyReason <service>|C3245478|[idcn]|["service"-tx-1-"Service"-noun-0]|TX|95/7|
00000000|MMI|3.11|Services|C0557854|[ocac]|["Service"-tx-1-"Service"-noun-0]|TX|95/7|
00000000|MMI|3.11|Software Service|C2825316|[mnob]|["Service"-tx-1-"Service"-noun-0]|TX|95/7|
00000000|MMI|3.11|Thousand per Deciliter|C2348779|[qnco]|["10^3/dL"-tx-2-"10.3 dL"-noun-0]|TX|624/4,631/2|
00000000|MMI|3.11|1-2|C3843716|[fndg]|["1-2"-tx-40-"1/2"-fraction-0]|TX|5670/3|
00000000|MMI|3.11|1/2|C0580272|[inpr]|["1/2"-tx-40-"1/2"-fraction-0]|TX|5670/3|
00000000|MMI|3.11|End|C0444930|[spco]|["End"-tx-51-"END"-noun-0]|TX|6784/3|
00000000|MMI|3.11|Phase I/II Trial|C1519043|[resa]|["1-2"-tx-40-"1/2"-fraction-0]|TX|5670/3|
00000000|MMI|3.11|Responsible to|C1273518|[fndg]|["Responsible"-tx-13-"Responsible"-adj-0]|TX|2688/11|
00000000|MMI|3.11|Stop (qualifier value)|C2746065|[tmco]|["End"-tx-51-"END"-noun-0]|TX|6784/3|
00000000|MMI|3.09|Baseline|C1442488|[qnco]|["Baseline"-tx-14-"baseline"-noun-0]|TX|3574/8|
00000000|MMI|3.09|Checking (action)|C1283174|[acty]|["Checked"-tx-38-"checked"-verb-0]|TX|5521/7|
00000000|MMI|3.09|Clipperton Island|C4050020|[geoa]|["CP"-tx-18-"CP"-noun-0]|TX|3939/2|
00000000|MMI|3.09|Elevated|C3163633|[qlco]|["Elevated"-tx-34-"elevated"-verb-0]|TX|5282/8|
00000000|MMI|3.09|Having administered|C1521801|[ftcn]|["Administered"-tx-44-"administered"-verb-0]|TX|6278/12|
00000000|MMI|3.09|High|C0205250|[qlco]|["Elevated"-tx-34-"elevated"-verb-0]|TX|5282/8|
00000000|MMI|3.09|House (environment)|C2003847|[mnob]|["House"-tx-40-"house"-adj-0]|TX|5689/5|
00000000|MMI|3.09|June|C3829443|[tmco]|["June"-tx-49-"June"-noun-0]|TX|6668/4|
00000000|MMI|3.09|Return to (contextual qualifier) (qualifier value)|C0332156|[qlco]|["Return"-tx-45-"return"-noun-0]|TX|6363/6|
00000000|MMI|3.08|Aspects of signs|C0220912|[ftcn]|["signs"-tx-31-"signs"-noun-0]|TX|5111/5|
00000000|MMI|3.08|Kilogram|C0439209|[qnco]|["kg"-tx-47-"kg"-noun-0]|TX|6506/2|
00000000|MMI|3.08|Manufactured sign|C0220913|[mnob]|["signs"-tx-31-"signs"-noun-0]|TX|5111/5|
00000000|MMI|3.08|More|C0205172|[ftcn]|["More"-tx-47-"more"-adv-0]|TX|6494/4|
00000000|MMI|3.08|Negative - answer|C3853545|[qlco]|["NEG"-tx-40-"neg"-noun-0]|TX|5637/3|
00000000|MMI|3.08|Per Kilogram|C4054209|[qnco]|["/kg"-tx-47-"kg"-noun-0]|TX|6506/2|
00000000|MMI|3.08|Physical findings|C0311392|[fndg]|["SIGNS"-tx-31-"signs"-noun-0]|TX|5111/5|
00000000|MMI|3.08|Dose number|C1115464|[qnco]|["Dose number"-tx-10-"Number Doses"-noun-0]|TX|2029/6,2039/5|
00000000|MMI|3.08|Call (Instruction)|C1947967|[ftcn]|["Call"-tx-38-"called"-verb-0]|TX|5543/6|
00000000|MMI|3.08|Decision|C0679006|[menp]|["Call"-tx-38-"called"-verb-0]|TX|5543/6|
00000000|MMI|3.08|Beans (food)|C0004896|[food]|["Beans"-tx-14-"beans"-noun-0]|TX|3614/5|
00000000|MMI|3.08|Changed status|C0443172|[qnco]|["change"-tx-25-"Change"-noun-0]|TX|4692/6|
00000000|MMI|3.08|Changing|C0392747|[ftcn]|["Change"-tx-25-"Change"-noun-0]|TX|4692/6|
00000000|MMI|3.08|Conditional|C1701901|[qlco]|["Contingent"-tx-1-"CONTINGENT"-noun-0]|TX|150/10|
00000000|MMI|3.08|Delta (difference)|C1705241|[qnco]|["Change"-tx-25-"Change"-noun-0]|TX|4692/6|
00000000|MMI|3.08|Disease Response|C1704632|[fndg]|["Response"-tx-27-"response"-noun-0]|TX|4829/8|
00000000|MMI|3.08|Limited (extensiveness)|C0439801|[ftcn]|["Limited"-tx-27-"limited"-adj-0]|TX|4821/7|
00000000|MMI|3.08|Limited Lifting Ability|C4050251|[inpr]|["Limited"-tx-27-"limited"-adj-0]|TX|4821/7|
00000000|MMI|3.08|Limited Walking Ability|C2674459|[fndg]|["Limited"-tx-27-"limited"-adj-0]|TX|4821/7|
00000000|MMI|3.08|Limited component (foundation metadata concept)|C3542948|[inpr]|["Limited"-tx-27-"limited"-adj-0]|TX|4821/7|
00000000|MMI|3.08|Response (communication)|C2911692|[menp]|["Response"-tx-27-"response"-noun-0]|TX|4829/8|
00000000|MMI|3.08|Response (statement)|C1706817|[inpr]|["Response"-tx-27-"response"-noun-0]|TX|4829/8|
00000000|MMI|3.08|Response process|C0871261|[orga]|["Response"-tx-27-"response"-noun-0]|TX|4829/8|
00000000|MMI|3.08|Used by|C1273517|[fndg]|["used"-tx-1-"USED"-verb-0]|TX|198/4|
00000000|MMI|3.07|Change of medication|C0580105|[topp]|["medication change"-tx-44-"changes medications"-noun-0]|TX|6097/7,6113/11|
00000000|MMI|3.07|Disease classification level|C0456079|[clas]|["Level"-tx-2-"level"-noun-0]|TX|600/5|
00000000|MMI|3.07|Floor - story of building|C1547707|[geoa]|["Level"-tx-2-"level"-noun-0]|TX|600/5|
00000000|MMI|3.07|HPX wt Allele|C3814444|[gngm]|["HX"-tx-13-"hx"-noun-0]|TX|3315/2|
00000000|MMI|3.07|Level|C2946261|[phsu]|["Level"-tx-2-"level"-noun-0]|TX|600/5|
00000000|MMI|3.07|Levels (qualifier value)|C0441889|[qlco]|["Level"-tx-2-"level"-noun-0]|TX|600/5|
00000000|MMI|3.07|Medical History|C0262926|[fndg]|["Hx"-tx-13-"hx"-noun-0]|TX|3315/2|
00000000|MMI|3.07|Present|C0150312|[qnco]|["Present"-tx-13-"presents"-verb-0]|TX|3419/8|
00000000|MMI|3.07|Presentation|C0449450|[idcn]|["Present"-tx-13-"presents"-verb-0]|TX|3419/8|
00000000|MMI|3.07|Progressive|C0205329|[ftcn]|["Progressive"-tx-13-"progressive"-adj-0]|TX|3443/11|
00000000|MMI|3.06|1/5|C0450316|[qnco]|["1/5"-tx-15-"1/5"-fraction-0]|TX|3707/3|
00000000|MMI|3.06|Cancer/Testis Antigen|C3813556|[aapp]|["CT"-tx-43-"CT"-noun-0]|TX|5966/2|
00000000|MMI|3.06|Computed Tomography Study File|C3888140|[inpr]|["CT"-tx-43-"CT"-noun-0]|TX|5966/2|
00000000|MMI|3.06|Discontinued|C1444662|[fndg]|["D/C"-tx-1-"D/C"-noun-0]|TX|185/3|
00000000|MMI|3.06|Doctor of Chiropractic|C1512015|[inpr]|["D.C."-tx-1-"D/C"-noun-0]|TX|185/3|
00000000|MMI|3.06|Labored breathing|C0553668|[sosy]|["Labored breathing"-tx-20-"labored breathing"-adj-0]|TX|4026/17|
00000000|MMI|3.06|PCYT1A wt Allele|C3540513|[gngm]|["CT"-tx-43-"CT"-noun-0]|TX|5966/2|
00000000|MMI|3.05|Lisinopril 40 MG|C0987221|[clnd]|["Lisinopril 40 MG"-tx-3-"LISINOPRIL 40 MG"-noun-0]|TX|946/16|
00000000|MMI|3.04|Aspirin 325 MG|C0992015|[clnd]|["Acetylsalicylic Acid 325 MG"-tx-2-"ACETYLSALICYLIC ACID 325 MG"-noun-0]|TX|350/27|
00000000|MMI|3.03|ACACA wt Allele|C3541413|[gngm]|["ACC"-tx-29-"acc"-noun-0]|TX|4934/3|
00000000|MMI|3.03|Alert|C3665546|[ftcn]|["Alert"-tx-6-"Alert"-adj-0]|TX|1447/5|
00000000|MMI|3.03|Alert:Type:Point in time:^Patient:Nominal|C3669039|[clna]|["Alert"-tx-6-"Alert"-adj-0]|TX|1447/5|
00000000|MMI|3.03|Causing|C0678227|[ftcn]|["Causing"-tx-13-"Causing"-adj-0]|TX|2716/7|
00000000|MMI|3.03|Chronic kidney disease stage 5|C2316810|[dsyn]|["Chronic renal failure"-tx-2-"Chronic Renal Failure"-noun-0]|TX|689/21|
00000000|MMI|3.03|Cognitive function: initiation|C0589507|[menp]|["Initiation"-tx-2-"Initiation"-noun-0]|TX|732/10|
00000000|MMI|3.03|Consciousness clear|C0239110|[fndg]|["ALERT"-tx-6-"Alert"-adj-0]|TX|1447/5|
00000000|MMI|3.03|Effect|C1280500|[qlco]|["Effect"-tx-30-"effect"-noun-0]|TX|5001/6|
00000000|MMI|3.03|Effect, Appearance|C2348382|[qlco]|["Effect"-tx-30-"effect"-noun-0]|TX|5001/6|
00000000|MMI|3.03|Evening|C0587117|[tmco]|["Evening"-tx-47-"evening"-adj-0]|TX|6535/7|
00000000|MMI|3.03|Initiation|C1704686|[ftcn]|["Initiation"-tx-2-"Initiation"-noun-0]|TX|732/10|
00000000|MMI|3.03|Pyrexia of unknown origin (excl puerperal)|C0856281|[sosy]|["puo"-tx-2-"PUO"-noun-0]|TX|648/3|
00000000|MMI|3.03|Transcription Initiation|C1158830|[genf]|["Initiation"-tx-2-"Initiation"-noun-0]|TX|732/10|
00000000|MMI|3.03|Yes (indicator)|C1705108|[cnce]|["YES"-tx-1-"YES"-noun-0]|TX|223/3|
00000000|MMI|3.03|Yes - Yes/no indicator|C1549445|[idcn]|["Yes"-tx-1-"YES"-noun-0]|TX|223/3|
00000000|MMI|3.03|carotid|C0741968|[bpoc]|["Carotid"-tx-20-"carotid"-adj-0]|TX|4066/7|
00000000|MMI|3.03|dictated - DocumentCompletion|C1609990|[idcn]|["Dictated"-tx-50-"dictated"-adj-0]|TX|6688/8|
00000000|MMI|3.03|dictated - ParticipationMode|C1548384|[ftcn]|["dictated"-tx-50-"dictated"-adj-0]|TX|6688/8|
00000000|MMI|3.02|Microgram per Inhalation|C2827876|[qnco]|["mcg/inh"-tx-10-"MCG INH"-noun-0]|TX|1978/7|
00000000|MMI|3.01|Impaired exercise tolerance|C0424551|[fndg]|["DECREASED EXERCISE TOLERANCE"-tx-15-"decreased exercise tolerance"-noun-0]|TX|3676/28|
00000000|MMI|3.01|/mL|C0439526|[qnco]|["/mL"-tx-28-"ml"-noun-0]|TX|4856/2|
00000000|MMI|3.01|Clinical Study Follow-up|C3274571|[hlca]|["FOLLOW-UP"-tx-10-"FOLLOW UP"-adj-0]|TX|2429/9|
00000000|MMI|3.01|Follow-Up Report|C1704685|[inpr]|["Follow-Up"-tx-10-"FOLLOW UP"-adj-0]|TX|2429/9|
00000000|MMI|3.01|Follow-up status|C0589120|[fndg]|["Follow-up"-tx-10-"FOLLOW UP"-adj-0]|TX|2429/9|
00000000|MMI|3.01|Importance Weight|C1705104|[idcn]|["Weight"-tx-10-"weight"-noun-0]|TX|2382/6|
00000000|MMI|3.01|PSMD3 gene|C1419033|[gngm]|["S3"-tx-20-"s3"-noun-0]|TX|4086/2|
00000000|MMI|3.01|RPS3 gene|C1335643|[gngm]|["S3"-tx-20-"s3"-noun-0]|TX|4086/2|
00000000|MMI|3.01|Regular exercise (observable entity)|C0582191|[dora]|["Regular exercise"-tx-10-"regular exercise"-noun-0]|TX|2412/16|
00000000|MMI|3.01|S3 (sacral segmental innervation)|C1179706|[blor]|["S3"-tx-20-"s3"-noun-0]|TX|4086/2|
00000000|MMI|3.01|SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS SYNDROME|C3542022|[dsyn]|["SOFT"-tx-20-"Soft"-adj-0]|TX|4196/4|
00000000|MMI|3.01|Soft|C0205358|[qlco]|["Soft"-tx-20-"Soft"-adj-0]|TX|4196/4|
00000000|MMI|3.01|THPO wt Allele|C1705224|[gngm]|["ML"-tx-28-"ml"-noun-0]|TX|4856/2|
00000000|MMI|3.01|Testicular Cancer Serum Markers Test Result S3|C3812877|[lbtr]|["S3"-tx-20-"s3"-noun-1]|TX|4086/2|
00000000|MMI|3.01|Thrombopoietin, human|C3887665|[aapp,bacs]|["ML"-tx-28-"ml"-noun-0]|TX|4856/2|
00000000|MMI|3.01|Weighing patient|C1305866|[diap]|["weight"-tx-10-"weight"-noun-0]|TX|2382/6|
00000000|MMI|3.01|follow-up|C1522577|[hlca]|["Follow Up"-tx-10-"FOLLOW UP"-adj-0]|TX|2429/9|
00000000|MMI|3.01|Simvastatin 40 MG|C0989916|[clnd]|["Simvastatin 40 MG"-tx-5-"SIMVASTATIN 40 MG"-noun-0]|TX|1340/17|
00000000|MMI|3.01|Niferex-150|C0212018|[orch,phsu]|["Niferex-150"-tx-3-"NIFEREX-150"-noun-0]|TX|1042/11|
00000000|MMI|3.00|Anterior|C0205094|[ftcn]|["ANTERIOR"-tx-20-"anterior"-adj-0]|TX|4268/8|
00000000|MMI|3.00|Current (present time)|C0521116|[tmco]|["CURRENT"-tx-35-"current"-adj-0]|TX|5310/7|
00000000|MMI|3.00|Decreased|C0205216|[qnco]|["Decreased"-tx-20-"decreased"-adj-0]|TX|4142/9|
00000000|MMI|3.00|Decreasing|C0442797|[qlco]|["decreased"-tx-20-"decreased"-adj-0]|TX|4142/9|
00000000|MMI|3.00|Electrical Current|C1705970|[npop]|["Current"-tx-35-"current"-adj-0]|TX|5310/7|
00000000|MMI|3.00|Entire lower leg, from knee to ankle|C1285009|[blor]|["Leg"-tx-13-"leg"-noun-0]|TX|3495/3|
00000000|MMI|3.00|Entity Name Part Type - given|C1550718|[idcn]|["given"-tx-35-"Given"-adj-0]|TX|5299/5|
00000000|MMI|3.00|GIVEN|C1442162|[cnce]|["GIVEN"-tx-35-"Given"-adj-0]|TX|5299/5|
00000000|MMI|3.00|Given name|C3244317|[inpr]|["given"-tx-35-"Given"-adj-0]|TX|5299/5|
00000000|MMI|3.00|Patient Condition Code - Stable|C1547311|[inpr]|["Stable"-tx-48-"Stable"-adj-0]|TX|6571/6|
00000000|MMI|3.00|Pitting edema|C0333243|[sosy]|["pit edema"-tx-20-"pit edema"-noun-0]|TX|4230/9|
00000000|MMI|3.00|Reduced|C0392756|[qlco]|["Decreased"-tx-20-"decreased"-adj-0]|TX|4142/9|
00000000|MMI|3.00|Stable status|C0205360|[qlco]|["STABLE"-tx-48-"Stable"-adj-0]|TX|6571/6|
00000000|MMI|3.00|Tablet Dosing Unit|C1705223|[qnco]|["Tab"-tx-3-"TAB"-noun-0]|TX|1116/3|
00000000|MMI|3.00|Transdermal Route of Drug Administration|C0040652|[ftcn]|["TRANSDERMAL"-tx-20-"transdermal"-adj-0]|TX|4282/11|
00000000|MMI|3.00|transdermal|C0694643|[spco]|["Transdermal"-tx-20-"transdermal"-adj-0]|TX|4282/11|
00000000|MMI|3.00|Stage level 4|C0441772|[inpr]|["Stage 4"-tx-31-"stage 4"-noun-0]|TX|5149/7|
00000000|MMI|3.00|treatment options|C0683525|[topp]|["treatment option"-tx-36-"treatment option"-noun-0]|TX|5446/16|
00000000|MMI|2.99|Teaching principal|C0401925|[prog]|["Principal"-tx-13-"PRINCIPAL"-adj-0]|TX|2657/9|
00000000|MMI|2.99|Topical surface|C0332237|[spco]|["Topical"-tx-3-"TOPICAL"-adj-0]|TX|999/7|
00000000|MMI|2.99|microgram|C0439211|[qnco]|["mcg"-tx-2-"MCG"-noun-0]|TX|414/3|
00000000|MMI|2.99|miscellaneous Crenarchaeota group|C3463985|[arch]|["MCG"-tx-2-"MCG"-noun-0]|TX|414/3|
00000000|MMI|2.99|Labetalol hydrochloride|C0699440|[orch,phsu]|["labetalol hcl"-tx-2-"LABETALOL HCL"-noun-0]|TX|803/13|
00000000|MMI|2.99|A Proliferation-Inducing Ligand Measurement|C3811652|[lbpr]|["APRIL"-tx-10-"April"-noun-0]|TX|2208/5|
00000000|MMI|2.99|April|C3715024|[tmco]|["April"-tx-10-"April"-noun-0]|TX|2208/5|
00000000|MMI|2.99|Final Statistical Report|C3890900|[inpr]|["SR"-tx-10-"SR"-adj-0]|TX|1780/2|
00000000|MMI|2.99|Good|C0205170|[qlco]|["Good"-tx-20-"good"-adj-0]|TX|4247/4|
00000000|MMI|2.99|SR cell line|C3891546|[emod]|["SR"-tx-10-"SR"-adj-0]|TX|1780/2|
00000000|MMI|2.99|Skin Response Domain|C3813610|[inpr]|["SR"-tx-10-"SR"-adj-0]|TX|1780/2|
00000000|MMI|2.99|TNFSF13 wt Allele|C3715025|[gngm]|["APRIL"-tx-10-"April"-noun-0]|TX|2208/5|
00000000|MMI|2.99|Food allergenic extracts|C3540798|[imft,phsu]|["food"-tx-10-"food"-noun-0]|TX|1932/4|
00000000|MMI|2.99|Once a day, at bedtime|C1275563|[tmco]|["qHS"-tx-5-"QHS"-noun-0]|TX|1361/3|
00000000|MMI|2.99|Room of building - Study|C0557651|[mnob]|["Study"-tx-13-"Study"-noun-0]|TX|2706/5|
00000000|MMI|2.99|Study|C2603343|[resa]|["Study"-tx-13-"Study"-noun-0]|TX|2706/5|
00000000|MMI|2.99|Transfusion (procedure)|C1879316|[topp]|["Transfusion"-tx-41-"transfusion"-noun-0]|TX|5814/11|
00000000|MMI|2.99|Transfusion - action|C0199960|[ftcn]|["Transfusion"-tx-41-"transfusion"-noun-0]|TX|5814/11|
00000000|MMI|2.99|September|C3828193|[tmco]|["September"-tx-2-"September"-noun-0]|TX|793/9|
00000000|MMI|2.98|Arikaree language|C1555622|[lang]|["Ris"-tx-40-"RISS"-noun-0]|TX|5700/4|
00000000|MMI|2.98|Atypical|C0205182|[qlco]|["Atypical"-tx-18-"atypical"-adj-0]|TX|3930/8|
00000000|MMI|2.98|CXADR wt Allele|C3540475|[gngm]|["CAR"-tx-1-"CAR"-noun-0]|TX|104/3|
00000000|MMI|2.98|Coxsackievirus and Adenovirus Receptor|C3539542|[aapp]|["CAR"-tx-1-"CAR"-noun-0]|TX|104/3|
00000000|MMI|2.98|Excessive|C0442802|[qlco]|["Excessive"-tx-45-"excessive"-adj-0]|TX|6412/9|
00000000|MMI|2.98|Hospital environment|C1510665|[qlco]|["Hospital"-tx-45-"hospital"-noun-0]|TX|6377/8|
00000000|MMI|2.98|Infusion procedures|C0574032|[topp]|["Infusion"-tx-18-"infusion"-noun-0]|TX|3947/8|
00000000|MMI|2.98|Infusion route|C1827465|[ftcn]|["Infusion"-tx-18-"infusion"-noun-0]|TX|3947/8|
00000000|MMI|2.98|NR1I3 wt Allele|C3811749|[gngm]|["CAR"-tx-1-"CAR"-noun-0]|TX|104/3|
00000000|MMI|2.98|RASL12 gene|C1428956|[gngm]|["RIS"-tx-40-"RISS"-noun-0]|TX|5700/4|
00000000|MMI|2.98|atypia morphology|C0741302|[fndg]|["Atypical"-tx-18-"atypical"-adj-0]|TX|3930/8|
00000000|MMI|2.98|site-specific telomere resolvase activity|C1622890|[moft]|["ResT"-tx-16-"rest"-noun-0]|TX|3844/4|
00000000|MMI|2.97|0/5|C0444499|[qnco]|["0/5"-tx-37-"5.0"-real_number-0]|TX|5493/3|
00000000|MMI|2.97|Behavior Rating Inventory of Executive Function|C4050216|[inpr]|["BRIEF"-tx-13-"BRIEF"-adj-0]|TX|3270/5|
00000000|MMI|2.97|Brief|C1879313|[tmco]|["Brief"-tx-13-"BRIEF"-adj-0]|TX|3270/5|
00000000|MMI|2.97|Prior Medication Usage|C2826257|[evnt]|["PRIOR"-tx-21-"prior"-adj-0]|TX|4377/5|
00000000|MMI|2.97|Shortened|C1282927|[qlco]|["brief"-tx-13-"BRIEF"-adj-0]|TX|3270/5|
00000000|MMI|2.97|Albuterol 2 MG|C1124741|[clnd]|["Albuterol 2 MG"-tx-10-"MG ALBUTEROL 2"-noun-0]|TX|2276/2,2285/9,2303/1|
00000000|MMI|2.97|ABD tumor staging notation|C0449202|[inpr]|["ABD"-tx-20-"Abd"-noun-0]|TX|4191/3|
00000000|MMI|2.97|Absence of Biallelic TCRgamma Deletion|C3811055|[comd]|["ABD"-tx-20-"Abd"-noun-0]|TX|4191/3|
00000000|MMI|2.97|Body Site Modifier - Lower|C1548802|[blor]|["Lower"-tx-20-"lower"-adj-0]|TX|4180/5|
00000000|MMI|2.97|Dental Base|C1880279|[bodm]|["Base"-tx-20-"base"-noun-0]|TX|4186/4|
00000000|MMI|2.97|Evaluation procedure|C1261322|[hlca]|["Evaluation"-tx-1-"evaluation"-noun-0]|TX|169/10|
00000000|MMI|2.97|HORNS IN SHEEP|C1832110|[fndg]|["HO"-tx-1-"HO"-noun-0]|TX|166/2|
00000000|MMI|2.97|Healthcare Encounters Domain|C3889614|[inpr]|["HO"-tx-1-"HO"-noun-0]|TX|166/2|
00000000|MMI|2.97|Lower (action)|C2003888|[acty]|["Lower"-tx-20-"lower"-adj-0]|TX|4180/5|
00000000|MMI|2.97|Lower - spatial qualifier|C0441994|[spco]|["LOWER"-tx-20-"lower"-adj-0]|TX|4180/5|
00000000|MMI|2.97|Onset of (contextual qualifier)|C0332162|[qlco]|["Onset"-tx-14-"onset"-noun-0]|TX|3656/5|
00000000|MMI|2.97|Recent|C0332185|[tmco]|["Recent"-tx-14-"recent"-adj-0]|TX|3537/6|
00000000|MMI|2.97|Structure of base of heart|C0225810|[blor]|["Base"-tx-20-"base"-noun-0]|TX|4186/4|
00000000|MMI|2.97|Symptom:Find:Pt:^Patient:Nom|C3854129|[clna]|["Symptom"-tx-14-"symptom"-noun-0]|TX|3648/7|
00000000|MMI|2.97|CYGB gene|C1424337|[gngm]|["HGB"-tx-2-"Hgb"-noun-0]|TX|596/3|
00000000|MMI|2.97|Hemoglobin concentration result|C0019029|[lbtr]|["HgB"-tx-2-"Hgb"-noun-0]|TX|596/3|
00000000|MMI|2.97|Hemoglobin measurement|C0518015|[lbpr]|["HGB"-tx-2-"Hgb"-noun-0]|TX|596/3|
00000000|MMI|2.97|Known|C0205309|[qlco]|["Known"-tx-2-"known"-adj-0]|TX|590/5|
00000000|MMI|2.97|Male Gender, Self Report|C1706180|[qlco]|["Male"-tx-13-"male"-noun-0]|TX|3310/4|
00000000|MMI|2.97|Male Phenotype|C1706428|[qlco]|["Male"-tx-13-"male"-noun-0]|TX|3310/4|
00000000|MMI|2.97|Male, Self-Reported|C1706429|[orga]|["Male"-tx-13-"male"-noun-0]|TX|3310/4|
00000000|MMI|2.97|Primary operation|C0439631|[topp]|["Primary"-tx-23-"primary"-adj-0]|TX|4502/7|
00000000|MMI|2.97|True primary (qualifier value)|C0439612|[tmco]|["Primary"-tx-23-"primary"-adj-0]|TX|4502/7|
00000000|MMI|2.96|Gram per Deciliter|C0439267|[qnco]|["g%"-tx-2-"g"-adj-0]|TX|629/1|
00000000|MMI|2.96|Local -Managed care POS|C3496399|[hcro]|["POS"-tx-24-"poss"-noun-0]|TX|4660/4|
00000000|MMI|2.96|Point-of-service (POS) plan|C3496112|[hcro]|["POS"-tx-24-"poss"-noun-0]|TX|4660/4|
00000000|MMI|2.96|Source|C0449416|[fndg]|["Source"-tx-24-"source"-noun-0]|TX|4665/6|
00000000|MMI|2.96|Term Source|C1705919|[inpr]|["Source"-tx-24-"source"-noun-0]|TX|4665/6|
00000000|MMI|2.96|Alveolar ventilation function|C0231940|[ortf]|["oxygenation"-tx-43-"oxygenation"-noun-0]|TX|5999/11|
00000000|MMI|2.96|Four times daily|C0585291|[tmco]|["QID"-tx-10-"QID"-adv-0]|TX|2314/3|
00000000|MMI|2.96|HCRT wt Allele|C3811761|[gngm]|["OX"-tx-43-"ox"-noun-0]|TX|5954/2|
00000000|MMI|2.96|Inhaler Dosing Unit|C1881212|[qnco]|["INHALER"-tx-10-"INHALER"-noun-0]|TX|2295/7|
00000000|MMI|2.96|Ox (organism)|C0300971|[mamm]|["Ox"-tx-43-"ox"-noun-0]|TX|5954/2|
00000000|MMI|2.96|Picofarad (unit of measure)|C1882376|[qnco]|["Puff"-tx-10-"PUFF"-noun-0]|TX|2305/4|
00000000|MMI|2.96|Poor - grade value|C0542537|[qlco]|["Poor"-tx-43-"poor"-adj-0]|TX|5949/4|
00000000|MMI|2.96|Poor - qualifier|C2700379|[qlco]|["Poor"-tx-43-"poor"-adj-0]|TX|5949/4|
00000000|MMI|2.96|Puff unit dose|C1533107|[qnco]|["PUFF"-tx-10-"